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ABSTRACT
Semiconductor nanocrystals, also known as quantum dots (QDs), are promising imaging probes
with characteristic optical properties: tunable bandgap from visible to infrared, narrow and
symmetric emission features, broad absorption, high quantum yield (QY), excellent
photostability, and a large two-photon absorption cross section. However, unlike other imaging
probes, the surface ligands determine the solubility, stability, quantum yield (QY),
biocompatibility, and derivatizability of QDs. Therefore, to use QDs for in vitro and in vivo
imaging, QD ligands need to be elaborately engineered for each experiment. Single cell labeling
in vivo requires extremely strict criteria for the QD conjugates to be used such as minimal
nonspecific cell/serum binding, maintenance of high QY in complex in vivo environments, and
compact size.
The focus of this thesis is the synthesis of high quality QD conjugates that can be used for single
molecule imaging in vivo and in vivo imaging studies that demonstrate the broad and powerful
applicability of our new methods. We incorporated novel conjugation methods employing highly
strained cycloolefins and a serum stable tetrazine derivative into newly developed polymeric
imidazole ligands (PILs) to efficiently couple biomolecules on QDs. Unlike traditional
conjugation methods, tetrazine-norbornene cycloaddition benefits from the non-interacting
properties of the functional groups to the QD surface, and yields the high conjugation
efficiencies on QDs. In addition, the rapid kinetics, absence of catalyst, and bio-orthogonality of
the cycloaddition allowed us to achieve in situ conjugation of the norbornene-bearing QDs to
tetrazine-bearing epidermal growth factor (EGF) proteins on the HeLa cell surface. On the in
vivo front, we accomplished single endogenous cell imaging in live mice. The ability to target
single cells using multiple biomarkers and track them for the extended periods of time allowed
us to study the microenvironment of the endogenous hematopoietic stem cells (HSCs), which
was not possible using conventional techniques engaging dye conjugated antibodies.
Lastly, a new class of QD ligands containing betaine moieties was developed to reduce the size
of QD conjugates, which we expect will be greatly beneficial for in vitro and in vivo targeting in
dense environments. We successfully demonstrated functionalization of the sulfonate betaine
5
poly imidazole ligands (SBPILs) with biomolecules, and the biocompatibility of SBPIL QDs
both in vitro and in vivo.
Thesis Supervisor: Moungi G. Bawendi, Ph.D.
Title: Lester Wolfe Professor of Chemistry
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Chapter 1. Introduction to Semiconductor Nanocrystals and
Their Applications in Biology
1.1 Colloidal Quantum Dots: Background, Theory, and Properties
Quantum dots (QDs), semiconductor nanocrystals, have gained much attention as a new
class of fluorescence probes for cellular and biomolecular imaging with their unique optical
properties such as tunable bandgap from visible to infrared, narrow and symmetric emission
features, broad absorption features, high quantum yield (QY), high photostability, and large two-
photon absorption cross section. In this chapter, we provide a basic theoretical background of
QDs and their optical properties, and compare QDs with organic dyes to demonstrate the
advantage of using QDs for bio-imaging.
1.1.1 Theory and the Physical Properties of Quantum Dots
1.1.1.1 Quantum confinement effect
Quantum dots are nanoscale crystalline assemblies of semiconducting materials
consisting of a few hundred to several thousand atoms. Their size ranges from 1.5 nm to 10 nm.
The small size of QDs confines spatial distribution of electrons and holes to the physical
dimension of the QDs. Because the size of QDs is usually comparable to or smaller than the
Bohr exciton radius of the particular semiconductor materials (ex. 5.6 nm for CdSe), quantum
confinement effects become critical in QDs. Confinement effects can be explained by simple
19
extension of a quantum mechanical particle in a one-dimensional box to a three-dimensional
sphere. As in a particle-in-a-box model, we expect the energy band diagram of QDs to be
discrete and the energy band gap to be influenced by the size of QDs, with the relation of 1/r2
Diamneter
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z /\\ (m)69A
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-~ ><~~ ~ -{e) 30A!
<;~- b)19 A
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Figure 1-1 Absorbance and emission spectra of a CdSe size series. Broad emission features of
the small QDs are originated from deep trap emission instead of bandedge emission. Figure
reproduced from C.B. Murray, Ph.D. Thesis, MIT, 1995.
Figure 1-1 confirms the theoretical prediction. As the size of CdSe QDs decreases, the
first absorption peaks and the bandedge emission peaks become blue-shifted. More detailed
theoretical explanations about quantum confinement effects in QDs are described in references
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[1, 2]. Tunability of bandgap as a function of size is one of the properties that make QDs
attractive for a wide range of applications.
1.1.1.2 Blinking (Fluorescence intermittency)
In 1996, Nirmal et al. reported fluorescence intermittency of a single CdSe QD under
continuous laser excitation [3]. As shown in Figure 1-2, the time-dependent fluorescence signal
from single nanocrystals exhibits a sequence of "on" and "off' periods; "on" and "off' times can
be as short as microseconds and as long as several minutes. It has been shown that the blinking
behavior of QDs is universal for various types of QDs [4-7] at various temperatures [8-10]. The
origin of QD blinking has not been fully explained, but it has been speculated that blinking is
related to charging of QDs. This hypothesis is strongly supported by previous experiments
showing that charged QDs are "dark", blinking and spectral shift are correlated [10], and local
electric field fluctuations trigger spectral shifts of single QDs [11]. A popular theoretical model
on blinking involves Auger recombination as a main cause of the blinking phenomenon.
According to this model, a "dark" state is triggered by extra charge formation in QDs via Auger
autoionization or thermal or tunnel autoionization of a nanocrystal and the ejected charge is
localized in a trap in the surrounding matrix [12].
L L 1. -
r r_ r- - -
0 5 10 15 20 25 30
time (s)
Figure 1-2 Time-dependent fluorescence signal from single CdSe/CdS QD. Y axis is I(t). Image
reproduced from G. Nair PhD Thesis, MIT 2009.
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Fluorescence intermittency is a serious drawback to the QD applications in single
molecule tracking and quantum informatics. Various efforts have been made to suppress blinking.
The first approach is adding "anti-blinking reagents." Since the blinking behavior is believed to
be related to charging of QDs, small molecules that can act as charge compensators or charge
mediators were added to stop blinking. Oligo(phenylene vinylene) [13] or thiol containing short
chains such as mercaptoethylamine [14], p-mercaptoethanol [15], dithiothreitol [15], and
thiopropionic acid [16] are reported to be effective in blinking reduction. For instance, 80% of
QDs show two or less blinking events for 80 seconds when 1mM of p-mercaptoethanol was
delivered. [15] The second approach is adding a thick inorganic shell layer around the QD core
to physically isolate the wavefunction of the QD core from the QD surface and environments.
Mahler et al. deposited 5.5 nm of crystalline CdS shell on CdSe cores that were 2.5 nm in
diameter to yield 13 nm diameter core-shell nanocrystals [17]. When the time-dependent
fluorescence traces of the single CdSe-CdS QD were recorded, only 5% of the QDs spent more
than 1% of their time in the "off" state. Similarly, Chen et al. also observed greatly suppressed
blinking behaviors in "giant" multishell CdSe nanocrystals (g-NQDs) [18]. They showed that
adding thicker shells can effectively decouple the wavefunction of the QD core from the surface
environments by showing constant quantum yield of the QDs after repeated
precipitation/redissolution (or crash-out) processes or phase transfer to water via ligand exchange
with mercaptosuccinic acid. In addition, they also showed that g-NQDs did not exhibit photo-
brightening or photo-darkening under intensive UV illumination for several hours. Wang et al.
took somewhat different route to illuminate blinking in QDs [19]. Instead of adding a thick
crystalline shell on the QD cores, they synthesized a graded alloy of CdZnSe/ZnSe core/shell
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QDs. Strikingly, these QDs exhibit no blinking over tens of minutes. They explained this
blinking-free phenomenon as a result of radiative recombination of a trion.
Synthesizing non-blinking, water-soluble, stable, derivatizable, and bio-compatible QDs
will enlarge the scope of QD applications as a single light source or as a probe for single
molecule imaging.
1.1.2 Comparison of Quantum Dots with Organic Dyes
QDs are thought to be excellent probes for fluorescent imaging. In this section,
physicochemical properties of organic dyes and QDs will be compared [20]. A summary of the
comparison between QDs and organic dyes is presented in Table 1-1.
Table 1-1 Comparison of properties of organic dyes and QDs.
Property Organic dye QD
Size Small molecule, less than 1 nm 6-60 nm (hydrodynamic diameter)
Molar extinction 0.25-2.5x 10' N 1 cm~' at the 0.5-5x 106 NVI cm- at 350 nm[21]
coefficient maximum absorbance (CdSe: 0.4 x105 M-' cm' unit cell-'
CdTe: 0.3 x105 M' cm-' unit cell-'
CdS: 0.5 x10 5 MI cm- unit cell-)*
Absorption Discrete bands, Shape is generally Continuous absorption below the band
spectra similar with the emission feature edge to UV. Increase toward shorter
wavelengths
Emission spectra Asymmetric, often has a long tail Symmetric, Gaussian profile, FWHM
toward long wavelengths, FWHM Visible (25-45 nm), NIR (60-100 nm)
35-100nm
Because QDs are composed of hundreds and thousands of unit cells, we showed the normalized molar extinction
coefficients and two-photon action cross sections per unit cell of a variety of QDs for better comparison with those
of organic dye molecules. Note that the normalized molar extinction coefficients of QDs are in the lower range of
the organic dye values, while the normalized two-photon action cross sections of QDs are in the upper range of the
organic dye values.
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Quantum yield
Two-photon
action cross-
section
Photochemical
stability
Thermal stabilit
Fluorescence
Lifetimes
Functionalizatio
Visible (0.5-1.0), NIR (0.01-0.10)
I x10~ 2 - 5x104 cm4 s photon7'
(typically 1 I X1049 cms photon-')
Usually photo-bleaches within
several seconds under intense laser
illumination for single molecule
spectroscopy, extremely bad for
NIR dyes
y Depends on dye class, bad for NIR
dyes
1- 5 ns
ri Easy, usually monovalent (by
proper molecule design)
Visible (0.3-1.0), NIR (0.1-0.6)
2x10 47  5x10 4 cms photon-'
(CdSe: 1.2 ~ 2.0 x10 cm4 s unit cell'
CdTe: -1.0 x10~49 cm 4s unit cell-)*
Does not photo-bleach under laser
illumination, photo-brightening or -
darkening can occur under extremely
high power excitation
High, depends on the shell and the
ligands
10 ns >1 ts, even longer for type II
QDs
Has to work through ligand chemistry,
usually multivalent
1.1.2.1 Size
Figure 1-3 shows the relative size of fluorophores compared to bio-compartments.
cy3 PE
Bacterium Animal cell
I W ul 9 111of1 qa WI a 0aIW II 1 51 I~
0.1 nm 1 10 100 1 pm 10 100
Figure 1-3 Relative size of fluorophores. Cy3 represents organic dye molecules (less than 1 nm)
and PE (phycoerythrin) represents fluorescent proteins (~ 10 nm). Hydrodynamic diameter of
QDs ranges from 6 nm to 50 nm depending on the size of the cores or the coatings.
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Organic dyes are small molecules which usually have length less than 1 im, while hydrodynamic
diameters of QDs range from 6 nm to 60 nm. Due to the large size of QDs, QD attachments can
change the dynamics of target molecules or trigger undesired biological pathways. Therefore,
when QDs are attached to relatively small bio-molecules, control experiments always have to be
performed by attaching smaller fluorescent probes instead of QDs to the target molecules.
Previous literature has shown that in vitro labeling of individual glycine receptors (GlyRs) using
QDs did not alter the diffusion dynamics of GlyRs in neurons [22]. However, our recent in vivo
studies indicate that labeling the endothelial cell surface using QD antibody conjugates (QD-Ab)
can change the endocytotic behavior of the cells (refer to Chapter 4).
1.1.22 Absorption features
The difference of QDs and dyes in their absorption features comes from different
molecular structures. QDs are nanoscale crystalline assemblies, which have both bulk-like and
atomic-like properties, while organic dyes are well-defined small molecules that have well-
defined molecular orbitals. As illustrated in Figure 1-4, energy diagram of QDs consists of
discretized energy levels near the bandedge and almost continuous bands far from the bandedge.
In contrast, organic dyes have well defined discretized energy levels consisting of electronic
energy states, vibrational energy states, and rotational energy states. Rotational energy states are
not illustrated in Figure 1-4. The bulk semiconductor-like band structure of QDs contributes to
the broad absorption features. In contrast, the discrete energy states of organic dyes result in
narrow and more discretized absorption features (Figure 1-5). The broad absorption features of
QDs are beneficial for their applications in multiplexing, because QDs of different colors can be
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excited simultaneously with a single light source. In the case of organic dyes, each dye often
needs its own excitation source since they have narrow absorbance features.
In addition, because QDs are composed of hundreds and thousands of repeated unit cells,
each of which acts as a dipole oscillator, QDs intrinsically have higher absorption cross sections
than organic molecules. Since brightness is defined by QY x absorption cross section at the
excitation wavelength, QDs can be brighter than dyes under the same excitation conditions.
1SWe-25.Ah)51S(e)-2S n(h) 1S(e)-1i2(h)1P(e)-lP3n(h) 1 S(e)-2S3a2(h)1S(e)-2S31n(h) +-15(e)-15 (h)
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Figure 1-4 Representative band diagram of bulk semiconductor, small QD, large QD, and
organic dye. Note that QDs have larger bandgap than bulk semiconductor and smaller QD has
bigger bandgap. Organic molecules have additional vibrational states.
1.1.2.3 Emission features
As well-defined molecules, dyes have discrete electronic states, vibrational energy states,
and rotational energy states (Figure 1-4). When a dye molecule is excited, the excited electron
decays to the ground vibrational level of the excited state via intraband relaxation. Then, the
excited electron radiatively decays to various vibrational states in the ground electronic state as
shown in Figure 1-5. This phenomenon leads to an emission spectrum containing multiple peaks
or shoulders. In contrast, QDs do not have defined vibrational energy states because of their
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bulk-like nature, and excited electrons can only decay to one ground state. Therefore, the
emission profile of QDs is usually narrow and Gaussian shape. (Figure 1-6 )t
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Figure 1-5 Representative electron transition diagram of (A) organic dyes and (B) QDs after UV
excitation. Red curves represent spectra absorption and blue curves represent emission spectra.
Because of their narrow and symmetric emission profile, more colors of QDs can be used
for multiplexed labeling without causing significant signal overlap. The ability to label multiple
cells or bio-molecules simultaneously is crucial for parallel analysis of different analytes or for
cell labeling in complex environments because multiple biomarkers are required to identify
1 Emission profile of QDs starts to show multi-peak features when they are excited with high power laser to
intentionally generate multi-excitons. However, a typical photon flux used for in vitro and in vivo imaging is much
lower and does not generate large population of multi-excitons.
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targeting cells [23-26]. In Chapter 4, we will demonstrate single hematopoietic stem cell labeling
using multiple biomarkers.
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Figure 1-6 Representative absorption and emission spectra of (A) QDs (CdSe/CdZnS) and (B)
organic dye (Dylight 550).
1.1.2.4 Stability
Fluorescence stability in buffers, blood serum and cell media under typical excitation
fluxes is one of the most important properties of fluorophores. However, organic dyes tend to
decompose under intense or long-term illumination and lose their photoluminescence. Recently,
much effort has been made to develop new classes of organic dyes with higher photostability[27,
28], but our unpublished work shows even newly developed dyes (ex. Alexa) photobleach within
several seconds under laser illumination with a typical photon flux that is used for cell imaging.
In contrast, core-shell QDs show exceptionally stable emission intensity profile under intense
illumination [29-31]. Our previous work shows that single QD labeling wild-type low density
lipoprotein receptors can be imaged for at least an hour [32]. This result is consistent with what
has been reported previously. Proper engineering of ligands might be crucial for QDs to retain
high QY for extended period of time in vitro and in vivo [33].
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1.1.2.5 Lifetime
QDs have comparatively longer radiative life than organic dyes; QDs have a lifetime of
five to hundreds of ns while visible dyes have lifetime of about 5 ns and NIR dyes have one of
about 1 ns. Within QDs made of the same materials, larger QDs have a longer fluorescence
lifetime (several hundred ns for CdSe emitting in red and tens of ns for CdSe emitting in green)
and type I QDs generally exhibit shorter lifetime than type II QDs. The significant difference in
lifetime allows us to separate QD fluorescence from background fluorescence through time-
domain imaging. [34]
1.2 Quantum Dot Applications in Biology
QDs have multiple advantages as imaging probes compared to organic dyes, such as high
photostability, broad absorption features, and narrow emission features. High-photostability
allows bio-molecule tracking that requires extended periods of viewing, and characteristic
absorption and emission features enable simultaneous imaging of different targets. In this
chapter, we are going to discuss various types of QD applications in biology.
1.2.1 Quantum Dots for Flow Cytometry Applications [35, 36]
With narrow and symmetric emission features and a large Stokes shift (up to 400 nm),
QDs are useful for multicolor flow cytometry. Signal leak-through to neighboring color channels
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is significantly less in case of QDs compared to organic dyes having the emission profiles with
the same full-width-half-maximum, since dyes commonly have red tails in their emission. In
addition, the large absorption cross section of QDs contributes to the high signal-to-noise value
in flow cytometry experiments. Figure 1-7 shows that cells labeled with Qdot655-CD4 display
signal-to-noise value that is 2 orders of magnitude bigger than cells labeled with
AmCyan(orgnanic dye)-CD4.
The effect of attachments of QDs (10 - 20 nm) to antibodies ( -12 nm) on the avidity of
the antibodies should be checked since large QDs can alter the dynamics of antibody labeling.
However, Figure 1-7 shows the concentrations of Qdot655-CD4 and AmCyan-CD4 required to
achieve half-saturation are very similar (1-2 nM). Based on this result, we can conclude that QDs
and organic dyes can be interchangeably used as fluorophores for flow cytometry experiments.
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Figure 1-7 Comparative titrations of Qdot655-CD4 and AmCyan-CD4. Red curve represents
labeling experiments using Qdot655-CD4 and blue curve represents labeling experiments using
AmCyan-CD4.
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1.2.2 Quantum Dots for in vitro Imaging
In early 2004, QD antibody conjugates (QD-Ab) became commercially available and
numerous publications on in vitro labeling of cells or bio-molecules using QDs and QD
conjugates have been reported. Targeting bio-molecules in cells using QD conjugates can be
achieved by two different methods
(A) (B)
secondary antibody
primary antibody
Figure 1-8 Two different routes to target biomarkers on the cell surface. (A) a receptor on the
cell surfice is labeled with a QD conjugated to the molecule that targets the receptor (B) an
antigen on the cell surface is first labeled with a primary antibody which is targeted by a QD
secondary antibody conjugate.
(Figure 1-8). In the first method (Figure 1-8A), target molecules are labeled with QDs that are
directly coupled to molecules that interact with target molecules (aiming molecules). QD-
streptavidin conjugates targeting biotinylated acceptor peptide (AP) Tag on cell surface is a
typical example [32]. In the second method (Figure 1-8B), cells of interest or antigens are first
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labeled using a primary antibody, followed by a QD secondary antibody conjugate. Secondary
antibodies bind to all of the primary antibodies that were raised in the same type of animals
(host); therefore, the same QD-secondary antibody conjugates can be used to label various types
of antigens. Commercially available QD-antibody conjugates involve this method.
1.2.2.1 Imaging offixed cells and tissues [37-47]
The easiest method to deliver QDs into cytosol to label intra cellular bio-molecules is
through cell fixation followed by permeabilization treatments. The detergent used to remove cell
membranes has to be chosen carefully so that the cellular structure of interest can be preserved
and the sites of interest can be labeled efficiently. Detailed procedures to fix and permeabilize
cells have to be optimized for each cell line and target.
(A) (B)
Figure 1-9 QD labeling on fixed cells. (A)HeLa cells are fixed with cold methanol/acetone and
labeled with QD secondary antibody conjugates. Green signal represents microtubules labeled
with a rat anti-tubulin antibody and a 525 nm QD anti-rat secondary antibody conjugate, yellow
signal represent golgi apparatus labeled with a rabbit anti-giantin antibody and a 585 nm QD
anti-rabbit secondary antibody conjugate, and red signal represents nucleus labeled with a mouse
anti-nuclesome antibody and a 655 nm QD anti-mouse secondary antibody conjugates. Scale bar
= 5 im. Image reproduced from Methods Mol Bio,2007, 374: p 5. (B) Immunostained section of
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adult mouse brain. Green signal represents NeuN, a marker of mature neurons, labeled with TSA
and QD525 streptavidin conjugate, yellow signal represents glial fibrillary-associated protein
labeled with a ribbit polyclonal antiserum and QD565 donkey anti-rabbit secondary antibody,
red signal represents microtubule-associated protein-2 labeled with a mouse monoclonal
antibody and QD605 goat anti-mouse seconday antibody, and blue signal represents nuclei
labeled with Hoescht33258 dye. Scale bar = 40 pm. Image reproduced from Methods Mol Bio,
2007, 374: p 24.
Figure 1-9A shows HeLa cells fixed and labeled with primary antibodies and QD
secondary antibody conjugates. Three different compartments in cells (microtubules, golgi
apparatus, and nuclei) were labeled using the different color QD conjugates. To simultaneously
label multiple types of biomarkers with QD conjugates of different colors, each set of biomarkers
should be labeled with primary antibodies that were raised in different animal host species. Then,
QDs conjugated to secondary antibodies that were raised against the host animals should be
incubated with the cells to target the corresponding primary antibodies.
QD conjugates can also be used for immunohistochemistry, the process of detecting
antigens in a tissue section. Immunohistochemical (IHC) staining is useful to understand spatial
distribution of biomarkers or proteins in different parts of tissues. To achieve the IHC staining,
harvested tissues were fixed, sectioned, treated with primary antibodies and lastly incubated with
QD secondary antibody conjugates (Figure 1-8B). Figure 1-9B shows a typical IHC staining
using QDs.
1.2.2 2 Imaging of live cells [22, 32, 48-521
Most publications on live cell imaging using QD conjugates demonstrate labeling target
molecules that are on the cell surface [22, 32, 48-52]. The exceptional photostability of QDs
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allows researchers to study detailed dynamics of the target molecules for extended periods of
time. Toxicity studies have shown that QDs do not affect the viability of cells when they are
coated with well-engineered ligands [24, 53, 54]. Criteria of the QD ligands to use the QDs for in
vitro applications are: neutral or slightly negative charge to prevent non-specific interaction with
cells and proteins, and possession of strong binding groups to the QD surface to prevent
detachment of the ligands.
Various efforts have been made to deliver QDs into the cytosol of live cells:
electroporation, microinjection, and endocytosis combined with the use of endosomal burst
reagents. The last method, utilizing endocytosis of QDs, is the most common approach because
electroporation and microinjection are destructive to cells. However, more studies need to be
done to promote QD release from endosomes while minimizing the cytotoxicity.
1.2.3 Quantum Dots for in vivo Imaging
Highly scattering and absorbing in vivo environments can benefit from the usage of near
infrared (NIR) QDs as probes. As shown in Figure 1-10, biological media exhibit low scattering
and absorption in 750~900 nm region. As a result, deeper tissues can be imaged using NIR
fluorophores than visible fluorephores [55]. Unfortunately, NIR organic dyes have extremely bad
thermal- and photostability [20], and therefore, developing biocompatible NIR QDs is of great
interest. Some of the works presented in the following sections utilize NIR QDs and demonstrate
deep organ or tumor detection.
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Figure 1-10 Absorbance spectra of the bio-molecules or bio-compartments in the NIR region. (A)
Absorption spectra for exygenated and deoxygenated hemoglobin, lipid and water. With the
absence of intense absorbing features, 750 - 850 nm is optimal for in vivo imaging. Figure
reproduced from W. Liu, Ph.D. Thesis, MIT, 2010. (B) Two NIR windows with low absorption
by biological media. Water Raman band exist around 1,000 nm. Image reproduced with
permission from Nat Nano, 2009. 4(11): p. 710-711. Copyright 2009 Nature Publishing Group
[56].
In vivo environments are much more complex than in vitro environments and contain a
variety of bio-molecules that can interact with QDs and quench their fluorescence or trigger
undesirable biological pathways. Therefore, elaborate engineering of ligands is critical to use
QDs for in vivo imaging. The following are the basic requirements for the ligands: 1) strong
binding to the QD surface to prevent detachment of the ligands which causes fluorescence
quenching, 2) controllable derivatizability to efficiently couple molecules that target the
molecules of interest (antibodies, peptides, DNA strands, etc.), and 3) minimal non-specific
binding nature (stealthy nature) of the ligand coated QDs to cells and serum proteins. In addition,
more requirements are added depending on specific in vivo applications. Due to the strict
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restrictions on the properties of ligands, new in vivo applications of QDs usually accompany new
ligand developments. In the following sections, we summarize previous reports on QD
applications in in vivo imaging and ligand developments.
1.2.3.1 Sentinel lymph node mapping [5 7-601
Sentinel lymph node (SLN) is the first lymph node to which metastasizing cancer cells
from a primary tumor are drained. It is believed that some types of cancer cells spread through
the lymphatic system--first to regional lymph nodes, then to other lymph nodes and so on.
Therefore, identifying and resecting the sentinel lymph node, known as sentinel lymph node
biopsy, is a common treatment to prevent further spread of the cancer cells.
In 2003, Kim et al. reported the use of NIR CdTe(CdSe) core(shell) type II QDs for
sentinel lymph node mapping. [60] QDs coated with oligomeric phosphine organic coatings were
injected intradermally and the QDs migrated to SLN within minutes. By using the NIR QDs,
they were able to identify SLNs that were approximately 1 cm below the skin surface with low
power NIR excitation (5 mW/cm2). They also showed that the fluorescence level of QDs stayed
constant over long period of time (at least up to 20 minutes) under laser illumination unlike the
dye-based SLN trackers.
The ligands used for this experiment, oligomeric phosphine organic coatings, were
synthesized by cross-linking monomeric alkyl phosphines and introducing functionality. The
multi-dentate binding moiety provides strong binding of the ligands to the QD surface, and the
carboxyliate moiety provides water-solubility and derivatizability. For the SLN mapping
experiments, QDs were injected without further functionalization.
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1.2.3.2 Tumor targeting [611
Taking a step further from the previous SLN experiments, QDs can be conjugated to
antibodies and used for targeting specific cells or receptors in vivo. For the specific targeting
experiments, the blood circulation half-life of QDs should be extended to promote active
targeting. Extending the circulation half-life of QDs can be achieved by coating the QD surface
with poly(ethylene glycol) (PEG) and making them non interactive with the environments.
In 2004, Gao et al. synthesized a new class of amphiphilic polymers to prepare water-
soluble QDs that can be used for tumor targeting in vivo. The encapsulating polymers contain
hydrophobic alkyl chains that intercalate with the native hydrophobic QD ligands, PEG chains
that provide water-solubility and biocompatibility, and carboxylic acid groups for further
functionalization. Using the newly developed encapsulated QD-antibody conjugates (eQD-Ab),
they targeted C4-2 human prostate tumors implanted in live mice after the systemic injection of
the QDs via the tail vein. Targeting solid tumors using QD conjugates involves ensemble
measurements of QD signals. Therefore, criteria for the QDs for such applications are not as
strict as the criteria for the QDs for single cell imaging in vivo. Single cell imaging in vivo has
not been achieved yet.
1.3 Quantum Dots for Other Biochemical Applications
With large absorption cross sections, high QY, narrow emission features and high
photostability, QDs are also useful for fluorescence based assays such as reverse-phase protein
micro arrays, multicolor sandwich immunoassays, multicolor genotyping assays, and
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competition immunoassays. In these examples, target molecules are detected by the fluorescent
signals coming from the QDs bound to the analytes. Representative examples can be found in
references [62-67].
Taking a step further from the previous examples, QDs themselves can be engineered so
that their emission profiles change in the presence of analytes. To synthesize such QD sensors,
QDs are conjugated to dyes that change the absorbance profile when bound to analytes (ex. pH,
PO2, etc.). Because F6rster resonance energy transfer (FRET) rate is highly dependent on the
spectral overlap between donor emission and acceptor absorbance, the change of the absorbance
spectra of the acceptor dyes will strongly influence the FRET efficiencies. Figure 1-11 is the
representative emission profile of a QD pH sensor. As we can see, the ratio between QD
emission and dye emission changes depending on the pH of the buffers. More detailed
information about the QD sensors can be found in reference [68].
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Figure 1-11 Emission profile of a QD pH sensor (QD squaraine dye conjugates) in different pH
buffers. As pH of buffers decrease, QD emissions (NC emission) are quenched and dye
emissions are enhanced.
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1.4 Thesis Overview
1.4.1 Background and Motives
The theme of this thesis is the development of bio-compatible ligands and conjugation
methods to synthesize QD conjugates that can be used for single cell imaging in vivo. Imaging
endogenous single cells in live animals can provide much information about cellular interactions
and their native environments in vivo. However, developing the QD conjugates for such
applications has been a big challenge because of the high standards required for the imaging
probes. Single cell imaging requires the tracking of single or few probes for extended periods of
time, while meso-sized object detection (solid tumor, sentinel lymph node, etc.) involves
ensemble measurements of the fluorescent signals over a large area at a certain time point.
Following are the detailed requirements for the QD conjugates to achieve single cell imaging in
vivo. First, QDs have to maintain high QY for extended periods of time in in vivo environments
which contain high concentrations of proteins, small molecules, and salts. Since ligand
detachment is thought to be the primary cause of the QY drop in such complex environments, we
need to develop ligands containing binding groups that have high binding affinity to the QD
surface and are chemically stable. Second, QD conjugates have to show minimal nonspecific
binding to cells and proteins to achieve specific targeting in vivo. Low nonspecific binding
nature (or the stealthy nature) of the probes becomes critical for single cell imaging, since even
small numbers of nonspecifically absorbed QDs can provide false signals or raise the
background signals. Third, efficient conjugation methods need to be developed to efficiently
couple QDs to the molecules that target the molecule of interest (aiming molecules). Traditional
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conjugation methods involve carboxylic acids, amines or thiols that are known to interact with
the QD surface. Therefore, only a small number of derivatizable groups is available for further
conjugation and conjugation efficiencies and reproducibility become low. Lastly, a smaller
hydrodynamic diameter for QD conjugates is better for efficient targeting. Reference [69, 70]
shows that small particles are known to diffuse faster in dense in vivo environments than larger
particles. Therefore, developing small particles can enhance targeting efficiencies in dense
environments such as solid tumor or bone marrow.
Recently developed PEG containing poly imidazole ligands (PEGPILs) are great
candidates for QD ligands. PEGPILs possess multidentate binding groups that are chemically
stable and strongly binding to the QD surface, and long poly (ethylene glycol) (PEG) chains that
provide exceptionally low protein/cell binding properties. However, the development of new
conjugation methods on PEGPIL QDs is required since traditional conjugations utilizing primary
amine groups are known to yield irreproducible and low conjugation efficiencies. Conjugation
efficiencies can be improved by incorporating more amines to the PILs, but increased number of
primary amines causes significant increase of nonspecific binding of the QD conjugates to cells
and proteins through positive charges on the QD surface. Therefore, in this thesis we
incorporated a new type of conjugation methods involving neutral molecules into the PEGPIL
ligand system. By combining all the recent advances in QD synthesis, ligand development and
conjugation method developments, we were able to demonstrate single endogenous cell labeling
using multiple QD antibody conjugates in live mice.
1.4.2 Thesis Summary
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In Chapter 2, we employ tetrazine-norbomene cycloaddition as a new conjugation
scheme on QDs. This catalyst-free click chemistry benefits from rapid kinetics, irreversibility,
bio-orthogonality, and non-interacting nature of the functional groups with the QD surface. In
addition, the reaction involves neutral molecules so that incorporation of more norbornene
groups on QDs do not affect the level of nonspecific protein/cell binding of the QDs. Taking
these advantages, we were able to show 1) highly efficient coupling of organic dyes, and proteins
on QDs using the tetrazine-norbornene cycloaddition as a conjugation method, and 2)
achievement of in situ clicking of QD-EGF to target EGFR on the HeLa cell surface.
In Chapter 3, we took a step forward and optimized the conjugation chemistry to
synthesize compact QD antibody conjugates (QD-Ab) that can be used for in vivo labeling.
Comparison with the commercial Qdot* 625 showed that our QDs are more compact and possess
far less nonspecific protein binding nature. Through in vivo vessel labeling, we were able to
optimize the ratio between QDs and antibodies in the QD conjugates to yield the best imaging
results and check the effect of the attachment of nano-sized QDs to antibodies. Finally, single
endogenous hematopoietic stem cells (HSCs) in bone marrow were successfully labeled and
imaged with high signal to noise ratio in live mice after systemic injection of the QD-Ab.
In Chapter 4, using the newly synthesized QD-Ab, we studied the microenvironment of
endogenous HSCs. This could not have been done with traditional dye-conjugated antibodies due
to the broad and assymetric emission features, and the low two photon cross section of organic
dyes. A series of experiments proved that HSCs preferentially reside in single vessel cavities,
and have normoxic niches. HSC niches being normoxic contradicts the generally accepted
hypothesis that HSC niches are hypoxic. These results highlight the importance of the in vivo
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QD-Ab labeling technique we presented in this thesis in studying cellular environment and
dynamics in live animals which was hard to achieve with the traditional techniques.
In Chapter 5, we explored a new type of ligands than traditionally used PEG based
ligands. Recent studies have shown that zwitterionic ligands exhibit extremely low bio-fouling
properties owing to the strong hydration capacity via electrostatic interactions. If we synthesize
bio-compatible zwitterioinc ligands, the hydrodynamic diameter of the zwitterionic QDs can be
significantly reduced from PEG containing QDs due to the absence of long PEG chains.
Therefore, in this chapter, betaine PILs were synthesized and the biological behaviors of betaine
PIL QDs were studied both in vitro and in vivo. The studies showed that betaine PIL QDs have
low nonspecific cell/protein binding nature and can be useful for in vitro targeting and in vivo
vessel tracing. However, long PEG chains seem to perform better at passivating QDs than the
betaine moieties since PEG PIL QDs exhibited more stealthy nature than betaine PIL QDs both
in vitro and in vivo.
In summary, this thesis explores new conjugation methods on QDs, synthesis of QD-
conjugates used for in vivo single cell imaging, the usage of the QD conjugates for in vitro and in
vivo imaging, and a new type of QD ligands.
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Chapter 2. Development of a Bioorthogonal and Highly
Efficient Conjugation Method for Quantum Dots using Tetrazine-
Norbornene Cycloaddition
2.1 Background and Motivation
Conventional quantum dot (QD) conjugation methods rely on functional groups such as
amines, carboxylic acids, and thiols that are known to interact with the QD surface [1, 2].
Surface coordination of functional groups can limit the number of available groups for further
coupling, resulting in low conjugation efficiencies [3]. An attractive alternative is to employ
coupling chemistry that requires functional groups that do not coordinate to the QD surface.
Click chemistries, such as the popular copper catalyzed azide-alkyne cycloaddition, are potential
alternative conjugation strategies [4-6]. However, for catalyzed "click" chemistry, the requisite
copper catalyst irreversibly quenches QD fluorescence (Figure 2-1). Additionally, catalyst-free
strain-promoted click reactions are limited by poor aqueous solubility of substrates and tedious
syntheses [7, 8]. Recently, there have been a number of examples that use inverse-electron-
demand Diels-Alder cycloadditions involving tetrazine and strained alkenes as an alternative
bioorthogonal conjugation method [9-11]. This chemistry benefits from sufficiently rapid
kinetics in that no catalyst is required. Recently, our collaborators have developed a tetrazine
derivative [3-(4-benzylamino)-1,2,4,5-tetrazine] (BAT) that shows good stability in buffer and
serum, and high reaction rate when reacted with strained olefins such as norbornene (Scheme 1,
2 M sI at 20 'C) [12] or trans-cyclooctene (-6000 M's~' at 37 0C) [13].
'Much of this chapter has appeared in print. It is reproduced with permission from JAm Chem Soc 2010, 132: 7838-
7839
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Figure 2-1 Quenching of QDs using Cu (I) ions. Absorption (A-C) and emission (D-F) spectra
of 1 M of QDs (in 200 pL 0.1 x PBS) after adding varying concentrations of Cu(I) (0 min). (G-I)
Relative emission intensity of the samples with varying concentration of Cu(I) to the control
sample without Cu(I) (0min). (J) Drop of the relative emission intensity of the QD samples with
1 x 10~9 mol of Cu(I) over time. (A, D, and G) are for CdSe/ZnS (5 monolayers of ZnS), (B, E,
and H) are for CdSe/Cdo. 3ZnO.7S (5 monolayers of Cdo. 3 Zno.7 S) and (C, F, and I) are for
CdSe/CdS(4 monolayers of CdS). The experimental data shows that CdS coated CdSe is most
prone to quenching by Cu(I). For all samples, an immediate drop of fluorescence is followed by
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a gradual decay of the emission intensity after the copper addition and the quenching is
irreversible. In general procedures for "click" chemistry [5, 14-16] on nanoparticles, >10-6 mol of
Cu(I) is used as a catalyst for ~ 10-10 mole of nanoparticles. With 10~6 mol of Cu(I), we observed
almost no emission from CdSe/ZnS, CdSe/Cdo. 3Zno.7 S, or CdSe/CdS.
Utilizing the non-coordinating properties of the substrates and the fast reaction rate, we
explored norbornene-tetrazine cycloaddition as a new, efficient conjugation method on QDs
(Scheme 1). Carboxylic acid modified norbornene (bicyclo[2.2.1]hept-5-en-2-yl acetic acid) was
selected for this study as it is commercially available and the carboxylic acid group allows
further conjugation to other molecules.
Scheme 1 Click chemistry between BAT and norbornene.
NH2 NH 2
R N- 2
N N R '11 i NH
N N
BAT
In this chapter, we present a bioorthogonal and modular conjugation method to efficiently
couple organic dyes and bio-molecules to QDs using a norbornene and tetrazine cycloaddition.
The use of non-coordinating functional groups combined with the rapid rate of the cycloaddition
leads to highly efficient conjugation. We apply this method to the in situ targeting of norbornene
coated QDs to live cancer cells that are labeled with tetrazine modified proteins.
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2.2 Synthesis of Norbornene Modified Polymeric Imidazole Ligands (NB-
PIL) and 3-(4-benzylamino)-1,2,4,5-tetrazine
The cycloaddition was achieved by functionalizing QDs with norbomene and reacting
with BAT-modified substrates. Polymeric imidazole ligands (PILs) were used to prepare
norbomene-coated water soluble QDs. PILs are random copolymers incorporating poly(ethylene)
glycol (PEG), amino-PEG 1 , and imidazole groups for water solubilization, functionalization,
and QD binding, respectively [3]. The modularity of the polymer and commercial availability of
the norbomene allows facile incorporation of norbomene groups on the polymer in gram scale.
For this study, poly(amino-PEG In)20%-PIL (NH2-PIL), composed of 30% poly(ethylene) glycol
(PEG 12), 20% amino-PEG 1 , and 50% imidazole groups, was further modified with n-
hydroxysuccinimide(NHS) activated bicyclo[2.2.1]hept-5-en-2-yl acetic acid (norbomene) via
amide coupling (Figure 2-2A). Complete conversion of amines to norbornenes was confirmed by
probing free amine in the polymer before and after the conjugation with fluorescamine, an
amine-reactive fluorogenic probe (Figure 2-3). Norbomene-coated QDs were prepared by ligand
exchange of natively capped QDs with the norbornene modified PIL (NB-PIL) (Figure 2-2B).
Gel filtration chromatography (GFC) data confirm that norbomene-coated QDs are well
dispersed in buffers without forming aggregates (Figure 2-4).
54
A.
H
-NH 2
NH2-PIL N-I
B.
H
0
Ligand Exchange
Figure 2-2 (A) Conjugation of norbornene to 20% NH2 -PIL polymer (B) Ligand exchange of the
native ligands of the QDs with the NB-PILs.
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Figure 2-3 Probing free amines in different polymer samples using fluorescamine. Black square
is poly(amino-PEG,1 )20%-PIL, red circle is poly(PEG 12)-PIL, blue triangle is after converting the
amine of poly(amino-PEGn1 )20%-PIL to norbornene (NB-PIL). Fluorescence of NB-PIL being
similar level as poly(PEG 12)-PIL proves that the conversion was complete.
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Figure 2-4 A representative GFC trace of NB-PIL QDs with a retention time of 4.5 minutes
corresponding to a hydrodynamic radius of -11 nm. The peak at 8 min corresponds to the free
NB-PIL ligand, and the peak at 9.4 min corresponds to the small molecule byproducts that are
formed during the modification of the poly(amino-PEG I )20%-PILs to NB-PILs.
2.3 Conjugation of Organic Dyes Using Tetrazine-Norbornene
Cycloaddition
To determine conjugation efficiencies of the cycloaddition on QDs, norbornene-coated
QDs were conjugated with BAT modified Alexa594 (Alexa-BAT) (Figure 2-5A). Representative
absorption and emission spectra of the QD-Alexa conjugates are shown in Figure 2-5B and C.
Coupling yields were determined through knowledge of the extinction coefficients of the dye and
QDs, along with measurement of the product absorption spectra. The number of Alexa dyes
conjugated to the norbornene coated QDs varied depending on the excess of Alexa-BAT (Figure
2-6A and B). The ratio of QDs to Alexa594 in the QD-Alexa conjugates was calculated using the
absorption values of the QDs and Alexa594 at 350 nm and 590 nm respectively (Table 1).
Increasing the dye concentration to 100x excess led to a saturation coupling yield of ~16
dyes/QD. We believe that this number effectively represents the average number of reactive
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norbornene molecules on the surface of each QD. One should be able to increase the number of
coupled dyes by further increasing the composition of norbornenes in the starting polymer.
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Figure 2-5 (A) Conjugation of BAT modified Alexa 594 to QDs using tetrazine-norbornene
cycloaddition. Representative (B) absorption and (C) emission spectra of the QD-dye conjugates
(-4 dye/dot) and the control samples without norbornene.
Table 1 QD-Alexa 594 conjugation ratios. Concentrations were measured based on sdye = 90,000
cm- M~' at 590nm for Alexa 594, and SQD = 2,630,000 cm~'M~' at 350nm for QD570.
Mixed QD Abs QD Cone. Dye Abs Dye Conc. Dye:QD
Dye:QD Ratio @ 350 nm (sM) @ 590 nm (pM) Ratio
10 0.251 0.0954 0.0350 0.388 4.07
40 0.425 0.162 0.165 1.83 11.3
100 0.431 0.164 0.245 2.72 16.6
200 0.442 0.168 0.232 2.58 15.4
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Figure 2-6 (A) Absorbance spectra of QD-Alexa conjugates which were prepared by mixing
carrying concentrations of the dye (B) Calculated Alexa to QD ratios for the purified conjugates.
2.4 In vitro Labeling Using QD-Protein Conjugates Prepared Using
Tetrazine-Norbornene Cycloaddition
To illustrate the utility of the coupling chemistry for live cell imaging with QDs, we
labeled epidermal growth factor receptors (EGFRs) overexpressed on the surface of human skin
cancer cells. Cellular labeling was achieved either directly through use of pre-formed QD-EGF
conjugates (Figure 2-7B) or by performing in situ conjugation of the norbomene-coated QDs to
BAT modified EGFs on the cell surface (Figure 2-7C). For direct labeling, the norbornene coated
QDs were coupled with BAT modified EGF (Figure 2-7A), and 50 nM of the resulting QD-EGF
conjugates were added to the A-431 human carcinoma cells at 4 "C for 30 mins (Figure 2-8).
Note that the quantum yield (QY) of the QDs stayed constant before and after the conjugation of
EGF to the QDs (Figure 2-9). By using low concentration of the QDs, we observed single QDs
that are characterized by their fluorescence intermittency (Figure 2-10). For in situ conjugation,
cells were incubated with 200 nM BAT modified EGF (BAT-EGF) at 4 "C for 30 minutes and
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labeled with 800 nM of norbornene coated QD at 37 "C for 30 mins (Figure 2-8D). Control
experiments using the same procedures but with QDs coated with poly(PEG 12)-PIL, composed of
50 % imidazole and 50% PEGI 2 (without norbornene), are shown in Figure 2-8A and 2-8C.
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+
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14 4)
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Figure 2-7 (A) Conjugation of NHS-activated BAT to EGF. (B) Labeling of cells with pre-
formed QD-EGF constructs. (C) In situ conjugation of norbornene-functionalized QDs to BAT-
EGF on live cells.
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Figure 2-8 Targeting of QDs to A431 squamous cancer cells using norbomene-tetrazine
cycloaddition. Top: QD fluorescence at 605 nm with excitation at 488 nm. Bottom:
corresponding DIC images (scale bar 10 gm). Cells were targeted either by (B) using preformed
QD-EGF complexes (50 nM) for single QD tracking or by (D) performing in situ conjugation
using norbornene-functionalized QDs (800 nM) on BAT-EGF-modified cell surfaces for
ensemble labeling. (A) and (C) are control experiment with poly(PEG 2)-PIL QDs (without
norbornene).
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Figure 2-9 Emission spectra of native QDs (black, QY ~100% in octane) and norbornene coated
QDs before (red, QY -60% in 1 xPBS) and after conjugation with EGF via norbornene-tetrazine
cycloaddition (blue, QY -60% in 1 xPBS). The initial quantum yield of norbornene coated QDs
is retained after the norbornene-tetrazine cycloaddition.
Figure 2-8 shows that successful labeling is achieved using either type of labeling
technique. The fast rate of the coupling reaction in serum allowed for in situ conjugation of
norbornene-coated QDs to BAT-EGF labeled cells. In addition, this method does not result in an
increased QD size, and in general works on cells with endogenously expressed receptors.
Figure 2-10 Time series of (from left to right) single QDs (arrows) bound to the surface of A431
squamous cancer cells showing blinking. Each frame was acquired with a 200 ms exposure time.
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2.5 Conclusion
In summary, we developed an efficient conjugation method for QDs utilizing the inverse
Diels-Alder cycloaddition between tetrazine and norbornene. The rapid kinetics combined with
the tolerance of the reaction to functional groups abundant in cells allows labeling of proteins of
interest on cells in situ. The conjugation approach presented here is modular and can be extended
to many biological imaging applications, as tetrazine and norbornene functionalities can be
easily conjugated to carboxylic acid or amine containing molecules.
2.6 Experimental Section
2.6.1 Materials and Instrumentation
All chemicals were purchased from Sigma Aldrich unless noted and were used as
received. Selenium shot, cadmium oxide 99.999%, and n-tetradecylphosphonic acid (TDPA)
were purchased from Alfa Aesar (Ward Hill, MA). Trioctylphosphine (TOP) and
tributylphospine (TBP) were purchased from Strem Chemicals (Buchs, Switzerland). Epithermal
Growth Factor (EGF, Human recombinant) and Alexa Fluor@ 594 carboxylic acid, succinimidyl
ester was purchased from Invitrogen. (1S,2S,4S)-bicyclo[2.2.1]hept-5-en-2-yl acetic acid was
purchased from ChemBridge. All solvents were of reagent grade or higher and were used
without further purification.
Tributylphosphine selenide (TBP-Se) was prepared by dissolving 0.15 mmol of selenium
shot in 100 mL of TBP under inert atmosphere and stirring vigorously overnight, forming a 1.5
M TBP-Se solution. All air sensitive materials were handled in an Omni-Lab VAC glove box
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under dry nitrogen atmosphere with oxygen levels < 0.2 ppm. All solvents were
spectrophotometric grade and purchased from EMD Biosciences.
Analytical HPLC and LC/MS were performed on a Waters 2695 HPLC equipped with a
2996 diode array detector, a Micromass ZQ4000 ESI-MS module, and a Grace-Vydac RPC 18
column (model 218TP52 10) at a flow rate of 0.3 mL/min. Preparative HPLC was performed on a
Varian ProStar model 210 instrument equipped with a model 335 diode array detector, a model
701 fraction collector, and a Varian RPC18 column (model A6002250X212) at a flow rate of 21
mL/min. All UV/vis spectra were recorded on an Agilent 8453 diode array UV/vis
spectrophotometer.
Photoluminescence and absorbance spectra were recorded with a BioTek Synergy 4
Microplate Reader. The absorbance of all solutions was kept below 0.1 OD to avoid inner-filter
effects. Flash column chromatography was performed on a Teledyne Isco CombiFlash
Companion. Polymer molecular weights were determined in DMF solutions on an Agilent 1100
series HPLC/GPC system with three PLgel columns (103, 104, 105 A) in series against narrow
polystyrene standards.
2.6.2 Synthesis
Synthesis of CdSe(CdS). CdSe cores with 480nm first absorption peak were synthesized using a
previously reported method [17]. To summarize, 0.4 mmol (54.1mg) of CdO, 0.8 mmol (0.2232g)
of TDPA, 9.6mmol (3.72g) of TOPO were placed in 25mL round bottom flask. The solution was
degassed for 1 hr at 160 'C and heated to 300 'C under argon until the CdO dissolved and
formed a clear homogenous solution. This was followed by putting the solution under vacuum at
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160 'C to remove the evolved water. The solution was reheated to 3600C under argon and a
TBP-Se solution (1.5mL of 1.5M TBP-Se in 1.5mL of TOP) was rapidly added to give CdSe
cores with the first absorption feature at 468nm. The cores were then grown further at 2600C to
produce cores with the desired wavelength for the first absorption feature.
CdS shells were deposited on CdSe cores via modification of previously reported procedures [3].
Cores isolated by repeated precipitations from hexane with acetone were brought to 180 'C in a
solvent mixture of oleylamine (3 mL) and octadecene (6 mL). Aliquots of Cd and S precursor
solutions were then introduced alternately starting with the metal (Cd) and waiting 15 min
between the start of each addition. The Cd precursor consisted of 0.33 mmol Cd-oleate and 0.66
mmol oleylamine in a solvent mixture of octadecene (1.5 mL) and TOP (3 mL). The S precursor
consisted of 0.3 mmol hexamethyldisilathiane [(TMS) 2S] in 6 mL TOP. The dose of each
overcoating precursor aliquot corresponds to adding a single monolayer of atoms to the QD
surface. Addition of a total of 4 aliquots each of Cd and S yielded QDs with emission at 570 nm
and a quantum yield close to unity when diluted in octane. A similar procedure was performed
on larger CdSe cores [18, 19] to obtain CdSe(CdS) QDs emitting at 605 nm. The extinction
coefficient of CdSe(CdS) was calculated using the extinction coefficient of CdSe cores from the
literature4 and assuming that 100% of the CdSe cores were retained during the overcoating step.
Figure 2-11 shows a transmission electron microscopy (TEM) image of the resulting CdSe(CdS)
QDs.
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Figure 2-11 TEM of CdSe(CdS) (em=570nm) with inorganic size -4.6 nm.
Preparation of amine-reactive tetrazine (Tz-NHS). 2,5-dioxopyrrolidin-1-yl 5-(4-(1,2,4,5-
tetrazin-3-yl)benzylamino)-5-oxopentanoate (Tz-NHS) was prepared from 3-(4-benzylamino)-
1,2,4,5-tetrazine (Tz-benzylamine) that was synthesized as previously described [12]. Tz-
benzylamine (10 mg) was added to a solution of methylene chloride containing 6 mg glutaric
anhydride. The solution was stirred overnight at 50'C. The methylene chloride was removed by
rotary evaporation and the crude mixture was purified by column chromatography resulting in 5-
(4-(1,2,4,5-tetrazin-3-yl)benzylamino)-5-oxopentanoic acid (Tz-acid) in quantitative yield. This
acid was then immediately introduced to an acetonitrile (2 mL) solution of N, N'-disuccinimidyl
carbonate (68 mg) and triethylamine (30 mg) and allowed to stir at room temperature until the
reaction reached completion (monitored by TLC). The acetonitrile was removed by rotary
evaporation and the crude mixture purified by column chromatography yielding 17 mg (80%
yield) of the desired Tz-NHS. 1HNMR (400 MHz CDCl3): 6 10.3-10.2 (s, 1H), 8.7-8.5 (d, 2H),
7.6-7.4 (d, 2H), 6.6-6.2 (br, 1H), 4.7-4.4 (m, 2H), 3.1-2 (in, 1OH). LR-MS [M+H]+ calc mass
399.1 found mass 399.2.
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Synthesis of norbornene conjugated polymeric imidazole ligands (NB-PIL). Poly(amino-
PEGI1)20%-PIL was synthesized using a previously reported method [3]. (1S,2S,4S)-
bicyclo[2.2.1]hept-5-en-2-yl acetic acid (norbomene) was activated by reacting 0.05 moles of
(1S,2S,4S)-bicyclo[2.2.1]hept-5-en-2-yl acetic acid with 0.06 moles n-hydroxysuccinimide
(NHS) and 0.06mol N,N'-Dicyclohexylcarbodiimide (DCC) in anhydrous tetrahydrofuran (THF)
for 2 hours at room temperature. NHS activated norbornene was reacted with Poly(amino-
PEGI 1)20%-PIL in dry THF overnight (2 times excess of norbornene was added to the number
of the amine groups in the polymer). After the reaction was completed, THF was removed by
vacuum and the reaction mixture was redissolved in ethylacetate to precipitate the byproducts.
Precipitates were filtered out using a 0.2 pM PTFE syringe filter. This workup was repeated
several times until no precipitate was observed after removal of the solvent.
Preparation of norbornene coated water soluble QDs. Ligand exchange of native QDs with
NB-PIL was performed as described in literature [3]. To summarize, QDs (1 nmol) were
precipitated using hexanes (30 pL), CHCl3 (30 pL) and EtOH(200 pL) and brought into 50 pL of
CHCl3. The QD stock solution was mixed with a solution of NB-PIL (4 mg) in CHCl3 (30 pL),
and stirred for 20 min at RT, after which 30 pL of MeOH was added followed by stirring for an
additional 20 min. QD samples were precipitated by the addition of EtOH (30 PL), CHCl3 (30
pL), and excess hexanes. The sample was centrifuged at 4,000 g for 2 minutes. The clear
supernatant was discarded, and the pellet dried in vacuo, followed by the addition of PBS (500
pL, pH 7.4). The aqueous sample was then filtered through a 0.2 pm syringe filter before use.
Prior to any conjugation chemistry or cell studies, free ligand was removed by three cycles of
dilution/concentration through an Amicon Ultra Ultracel 50,000 Da MW cutoff filter (Millipore).
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The quantum yield of norbornene coated QDs was about 60%. (Quantum yield of natively
capped QDs was ~100%).
Synthesis of 3-(4-benzylamino)-1,2,4,5-tetrazine conjugated Alexa 594. Alexa Fluor@ 594
carboxylic acid, succinimidyl ester (Alexa 594) was reactivated with n-hydroxysuccinimide by
adding 1.2equiv of NHS and 1.2equiv of DCC in dry DMF and reacted for 2 hours at room
temperature. 1 equiv of 3-(4-benzylamino)-1,2,4,5-tetrazine was added to the solution and
reacted overnight at room temperature. Completion of the reaction was confirmed using
ninhydrin staining.
Synthesis of EGF-BAT. Amine reactive tetrazine (4mg/mL) was reactivated with n-
hydroxysuccinimide by adding 1.2 equiv of NHS and 1.2 equiv of DCC in dry DMF and reacted
for 2 hours at room temperature. 50pug of EGF was dissolved in 200pL IX PBS and 1.2 equiv of
NHS activated tetrazine was added to the solution and reacted overnight at room temperature.
The conjugates were dialyzed three times with an Amicon Ultra Ultracel 3,000 Da Mw cutoff
filter (Millipore) to remove excess NHS, DCC and byproducts.
Synthesis of QD-Alexa594 conjugates. 200uL of 1IM norbornene coated QDs were mixed
with different concentrations of Alexa594 tetrazine in IX PBS and reacted for 4 hrs at 37 'C.
Excess reagents were removed by gel filtration chromatography and dialyzed three times with 1 x
PBS using Amicon Ultra Ultracel 50,000 Da MW cutoff filter. The control experiments were
performed using Poly(amino-PEGI i) 2 0%-PIL coated QDs. Final materials were analyzed by UV-
Vis absorption to determine the number of dyes on the QD surface. Concentrations of QDs and
Alexa 594 were measured based on sdye = 90,000 cm~'M-' at 590nm for Alexa 594, and &QD
2,630,000 cm-IM~' at 350nm for QD570.
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Synthesis of QD-EGF. 0.2nmol of norbornene coated QDs and 0.4 nmol of EGF-tetrazine were
mixed in IX PBS with a final concentration of 1pM for QDs and incubated for 2 hrs at 37 'C.
Unreacted EGF was removed by three cycles of dilution/concentration through an Amicon Ultra
Ultracel 50,000 Da MW cutoff filter (Millipore).
2.6.3 Characterization Methods
Fluorescamine Assay of Amine Reactivity PILs. Stock solutions of amine-containing PIL
polymers were made at 20 mg/mL concentration. A serial dilution was made using 1, 2, and 4 pL
of polymer stock into 240 pL of PBS buffer, followed by addition of 10 pUL of a 30 mg/mL
solution of fluorescamine in acetone. This mixture was vortexed and incubated at room
temperature for 1 hour before fluorescence analysis on a BioTek plate reader with excitation at
380 nm and detection at 480 nm. The recorded fluorescence intensity signals were calibrated
against solutions of known concentrations of methoxyPEG1 1-NH2.
Quantum yield (QY) of QDs. The QY of QD570 was measured relative to Rhodamine 610 (QY
68% in ethanol) with excitation at 505 nm and the QY of QD605 was measured relative to
Rhodamine 640 (QY 100% in ethanol with excitation at 535nm). Solutions of QDs in octane
(native CdSe/CdS QDs) or PBS (QDs after ligand exchange with either Poly(amino-PEG )20%-
PIL or NB-PIL) and dye in ethanol were optically matched at the excitation wavelength.
Fluorescence spectra of QD and dye were taken under identical spectrometer conditions in
quadruplicate and averaged. The optical density was kept below 0.1 at the kma, and the
integrated intensities of the emission spectra, corrected for differences in index of refraction and
concentration, were used to calculate the quantum yields using the expression QYQD =
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(Absorbance)ye/(Absorbance)QD x (Peak Area)QD /(Peak Area)Dye x (nQD solvent) 2/(nDye
solvent) 2 X QYDye-
Gel Filtration Chromatography (GFC). GFC was performed using an AKTAprime Plus
chromatography system from Amersham Biosciences equipped with a self-packed Superdex 200
10/100 column. PBS (pH 7.4) was used as the mobile phase with a flow rate of 1.0 mL/min.
Detection was achieved by measuring the absorption at 280 nm.
Transmission Electron Microscopy. The inorganic size of CdSe(CdS) QDs was determined
using a JEOL 200CX TEM operating at 200 kV. One drop of a dilute sample of QDs in hexane
precipitated two times using acetone was placed onto a Formvar coated copper grid, allowed to
settle for 20 seconds, and wicked away using an absorbent tissue. Size analysis was performed
on captured digital images using ImageJ 1.34s.
Cell culture and labeling. A-431 human epidermoid carcinoma cells were grown in DMEM
(Invitrogen) with 10% Fetal Bovine Serum (Invitrogen), 50 gg /mL penicillin and 50 pg /mL
streptomycin (Invitrogen). When labeling cells with preformed QD-EGF conjugates (Figure 2B),
cells were rinsed with 4 'C 1% Bovine Serum Albumin (BSA) in PBS and incubated with 50 nM
QD-EGF conjugates at 4 'C for 30 minutes. For in situ click conjugation between tetrazine and
norbornene on cells (Figure 2C), cells were rinsed with 4 'C 1% BSA in PBS, incubated with
200 nM EGF-BAT at 4'C for 30 minutes, and then rinsed three times with 1% BSA in PBS to
block non-specific binding. Subsequently, norbornene coated QDs at varying concentrations
were added to the cells and incubated for 30 minutes at 37 0C. The cells were then washed three
times with 25'C PBS to remove excess QDs.
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Fluorescence imaging. Cells were imaged with an epifluorescence microscope (Nikon) with a
60x water-immersion objective and Princeton instruments MicroMax Camera with a 1.5x
magnification tube lens. Bright field images were collected using differential interference
contrast with an exposure time of 100 ms and fluorescence images were collected by exciting
with a 488 nm Argon-ion laser line combined with a D605/30M emission filter. Exposure times
for fluorescence imaging were 200 ms for QD blinking time-lapse imaging and 500 ms for all
others. All fluorescence image frames were background corrected using Matlab.
Copper quenching. To verify that copper (I) ions quench the QD fluorescence irreversibly,
2x10-10 mol of CdSe/ZnS (5 monolayers of ZnS), CdSe/Cdo.3Zno.7S (5 monolayers of Cdo.3Zno.7 S)
and CdSe/CdS (4 monolayers of CdS) coated with poly (PEG 12)-PIL in 0.1 xPBS were incubated
with varying concentrations of Cu(I). Cu(I) was generated in situ by reducing Cu(II) with sodium
ascorbate.
100 mmol of CuSO 4 and 500 mmol of sodium ascorbate were dissolved in I mL of 0.1 x PBS
(Solution A). 1 pL, 3 pL, 10pL, 30pL, and 100 pL of solution A was added to 2 x 10-1 mmol of
QDs and the final volume was adjusted to 200 RL (0.1 x PBS). Absorption and emission spectra
of the samples were measured at 0min, 20min, 40min, 60min, and 80min after the copper
addition.
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Chapter 3. Development of Quantum Dot Antibody Conjugates
for in vivo Imaging of Single Endogenous Cells
3.1 Background and Motivation
Imaging single endogenous cells in a live animal for an extended period of time can
provide much information about cellular interactions and the microenvironment of the cells in a
living organism. However, the requirements for fluorescent probes used in single molecule
imaging in vivo are very restrictive due to the complexity of in vivo environments. Quantum dots
(QDs) are ideal candidates, possessing unique optical properties: a tunable bandgap ranging from
the visible to infrared, high quantum yield (QY), narrow and symmetric emission features, broad
absorption features below the band edge, large two-photon absorption cross sections, and high
photo-stability [1-4]. The tunability of emission wavelength enables the use of the near infrared
(NIR) window for in vivo imaging where there is low absorption and minimal scattering by
tissues and blood [5, 6]. Utilizing the NIR window has been difficult with organic dyes because
they tend to have low QY and low thermal- and photo- stability in the NIR [7-11]. Furthermore,
the narrow and symmetric emission features of QDs enable distinction of multiple bio-markers
and the broad absorption features allow simultaneous excitation of QDs with a single light source
[12-14]. Lastly, QDs generally have a two-photon absorption cross section that is two to five
orders of magnitude larger than organic dyes, making QDs favorable for two photon imaging [7,
15-17].
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Antibody (Ab) is a Y-shaped protein used by the immune system to recognize and bind to
foreign objects (antigens). Antibody can be raised to recognize any antigenic target of interest
(proteins, peptide, carbohydrate, or other small molecules), and therefore, is widely used for
targeting experiments. QD-Ab conjugates have been used to target cells or receptors of interest
both in vitro and in vivo [18-21]. However, most in vivo imaging studies using QD-Ab
conjugates have involved ensemble measurements of QD signals over large volumes such as
solid tumors.[21-24] This macro-environment context is due to a lack of technology for
synthesizing QD conjugates optimal for single cell microenvironment imaging. Previous reports
on single molecule tracking in live mice using commercial QD antibody conjugation kits have
shown the great potential of QDs as probes for in vivo imaging [25, 26]; however, the dearth of
publications in this field indicates the difficulty of obtaining reproducible in vivo data with high
signal to noise ratios using the existing techniques.
This chapter describes the development of quantum dot-antibody (QD-NB-Ab)
conjugates suitable for in vivo imaging by combining recent advances in QD synthesis, ligand
development and conjugation chemistry. The first enabling piece of our synthetic technology lies
in advanced QD synthesis. Recently developed core-shell QD syntheses produce QDs that are
small, bright, stable, and display narrow emission bands [6, 27, 28]. These properties of the QDs
make them optimal for multi-color imaging in highly scattering and biologically crowded
environments. The second enabling piece is the water solubilization technique employing newly
developed poly(imidazole) ligands (PILs) [27]. PILs are random co-polymers that incorporate
imidazole for QD binding, methoxy poly(ethylene glycol) (PEG) for water solubility and bio-
compatibility, and amino PEG for further derivitization. QDs that are ligand exchanged with the
PILs have small hydrodynamic diameters because PILs are directly coordinated to the QD
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surface. This is in stark contrast to the generally used encapsulated QDs that have an extra
hydrophobic ligand layer between amphiphilic polymers and the QD surface. The small size of
the PIL QDs enhances their diffusion in a biologically crowded environment [23]. In addition,
the multidentate imidazole motifs of PILs are chemically stable and exhibit a high affinity
towards the Cd and Zn-rich QD surfaces. Therefore, PILs passivate the QD surface effectively to
achieve high QY (80-90% [29]) in aqueous solution, greatly enhanced stability in buffers and
serum, and extremely low non-specific binding to serum and cells [27]. The third enabling piece
of our technology lies in the employment of the norbornene-tetrazine cycloaddition for the
conjugation of bio-molecules on QDs. Unlike functional groups involved in traditional
conjugations such as carboxyl groups, amine groups and thiols, tetrazine and norbornene show
minimal interactions with the QD surface and are therefore more accessible for the PIL QD
conjugation step. As shown previously, this catalysis-free click chemistry on QDs yield efficient
coupling of organic molecules and proteins to the QDs [30]. In this chapter, we utilized a
modified version of thisthis conjugation method to synthesize compact QD-NB-Ab conjugates.
3.2 Synthesis of QD-NB-Ab Conjugates
To prepare the QD-NB-Ab conjugates, norbornene-modified poly imidazole ligands (NB-
PIL) coated QDs (QD-NB) were conjugated with tetrazine modified antibodies as shown in
Figure 3-1. The NB-PILs were prepared by modifying primary amines of poly(amino-
PEGi 1)2o%-PIL (NH 2-PIL) with an amine-reactive norbornene species. We then exchanged the
native QD ligands with NB-PILs as described previously [30]. Tetrazine-modified antibodies
were prepared by reacting amine-reactive tetrazine with the lysine groups of antibodies. These
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were immediately conjugated to the NB-PIL coated QDs simply by mixing the two components
at room temperature for 22-24 hours; this step needs to be performed rapidly since tetrazine
degrades over time in aqueous solution [31]. After conjugation, unreacted tetrazine on the
antibodies were quenched to prevent aggregation. This conjugation scheme can be extended to
any QDs containing Cd or Zn on the surface and any antibodies containing lysine residues. In
this study, diverse combinations of QDs (CdSe/CdZnS, CdSe/CdS and InAs/CdZnS) and
antibodies (CD3 1, CD45, C-kit, Sca- 1, and IgG) were synthesized and used for imaging
experiments. All synthesized QDs used in this study are represented as QD_emission wavelength (nm).
Antibody (Ab)
Ab
4..4k Nortbomne
Figure 3-1 Conjugation of QDs to antibodies (Ab). Ab is represented by IgG2a and Lys residues
of IgG are marked by red balls.
3.3 Characterization
3.3.1 Nonspecific Serum Binding Studies for in vivo Experiments
Prior to using any QD-NB-Ab constructs for specific targeting in vivo, we first validated
the bio-compatibility of the NB-PIL coated QDs (QD612-NB) by incubating the QDs with fetal
bovine serum (FBS) at 370C for 4 to 6 hours. The size of the QD samples before and after
incubation was measured using fluorescent correlation spectroscopy (FCS, Figure 3-2) and
dynamic light scattering (DLS). The measurements show that the size of the particles does not
76
change after the serum incubation, in contrast to commercial Qdot* 625 that are encapsulated
with amphiphilic polymers (Invitrogen) which showed a significant size increase after serum
incubation (Table 3-1). Furthermore, the standard deviation of the QD 612-NB size remained the
same after incubation, indicating that they do not exhibit non-specific adsorption of serum
proteins (Table 3-1).
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Figure 3-2 Representative curves for Fluorescence Correlation Spectra measurements. The solid
blue lines are correlation factors G(t), the solid green lines are fitting regions, and the solid red
lines are fits of each measurements (a) NB-PIL coated QD612 before serum incubation, (b)NB-
PIL coated QD 612 after serum incubation, (c) Qdot* 625 before serum incubation, and (d) Qdot*
625 after serum incubation.
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Table 3-1 Hydrodynamic Diameter of the QD samples measured using DLS and FCS.
Inorganic Diameter (nm) Average Hydrodynamic
Diameter (nm)
QD612-NB 12.5 ± 0.2
QD612-NB + FBS at 370C for 4 hours 12.6 0.2
(measured using FCS) 5.8 ± 0.5
QD 6 2: CD31 = 1 : 1 14.5 ±0.4
QD612 : CD31 = 3: 1 15.3 0.8
Qdot" 625 (Invitrogen) 20.0 ±0.5
Qdotw 625 + FBS at 370C for 4 33.4 2.6
hours (measured using FCS) 9.0 ± 1.0
Qdot" 625 -CD31 20.5 0.6
3.3.2 Stability
In addition to the bio-compatibility, we observed that the PIL coated QD6 12 is more stable
in solution versus Qdot* 625. A simple test for stability is to centrifuge an aqueous solution of
QDs. If the QDs are aggregated or unstable, they will form precipiates at the bottom. Qdot 625
rapidly started forming preciptates after centrifugation for 5600 ref for 3 minutes, while the
QD612-NB QDs remained dispersed and homongenous in solution. This can be explained by
strong interactions between the multidentate imidazole moieties of the PILs and the Cd/Zn atoms
on the QD surface in QD612-NB, in contrast to the weak hydrophobic interaction between
amphiphilic polymers and the native hydrophobic ligands of QDs in Qdot* 625. Strong binding
of ligands to the QD surface is an important factor for maintaining high QY in vivo because
surface defects caused by ligand detachment can promote fluorescent quenching [32-34].
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3.3.3 Size
Another crucial factor for in vivo labeling using QDs is the hydrodynamic size of a QD-
NB-Ab construct. This hydrodynamic size will influence the bioavailability and clearance
properties of the particle in a live animal [22, 35]. The size of the QDs and the QD conjugates
was measured by DLS (Figure 3-3(b) and Table 3-1). As expected, both QD 612-NB and QD 612-
NB-Ab were more compact than Qdot* 625 and Qdot* 625-Ab. The compact size of the QD-
NB-Ab conjugates enhances access to biologically crowded regions and increases their diffusion
rate throughout densely packed in vivo environments.
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Figure 3-3 (a) DLS Data of the QDs and the QD-Ab conjugates. (b) Zeta potential measurement
of the QDs and the QD-Ab conjugates. (c) GFC traces of the NB-PIL coated QD612 before and
after the serum incubation.
3.3.4 Zeta potential
The charge of QDs also has a major effect on the transport behavior of nanoparticles in
vivo and in vitro [36]; high surface charge of nanoparticles, either positive or negative, tends to
cause non-specific uptake by macrophages which in turn cause more accumulation of the
particles in the liver rather than the targeted region after systemic administration. Zeta potential
measurements indicated that the surface charge of the QD-NB and the QD conjugates were
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relatively neutral (Figure 3-3(c) and Table 3-2). With the low nonspecific binding, small
hydrodynamic size, and neutral surface charge, the QD-PILs and the QD-NB-Ab conjugates
developed here appear optimal for in vivo labeling.
Table 3-2 Zeta potential measurement of the QDs and the QD-Ab conjugates.
Zeta Potential (mV)
QD612-NB -7.9 1.2
QD 612: CD31 = 3 : 1 -6.3 ±1.2
QD612 : CD31 = 1 : 1 -9.0 2.1
Qdote 625 (Invitrogen) -18.5 3.5
Qdote 625 -CD31 -7.7 1.6
3.4 Flow Cytometry Experiments
After the characterization of the QD complex, we tested the specificity of the QD-NB-Ab
conjugates in vitro using flow cytometry (Figure 3-4). Blood cells (excluding red blood cells)
were purified and used for labeling. First, non-specific binding of the QD-NB and the QD-NB-
Ab conjugates to cells was tested by incubating blood cells with QD57o-NB, QD612-NB, and
QD570-NB-IgG. As shown in Figure 3-4(a-c), no non-specific labeling was observed. Then,
QD6 12-NB-CD45 was incubated with the blood cells to label leukocytes. After incubation, >50%
of the blood cells showed high intensity of the QD612 emission; this number corresponds
approximately to the percentage of leukocytes out of all blood cells in the sample (Figure 3-4(d)).
Next, the blood cells were co-incubated with PE-Cy7 labeled CD45 (CD45-PE-Cy7) and QD5 70 -
NB-IgG to verify that QDs70-NB-IgG does not interfere with the interaction between leukocytes
and CD45-PE-Cy7. As expected, leukocytes were labeled only with CD45-PE-Cy7. A small
population of the cells shows up in the QD5 70 channel because a small portion of the emission
from PE-Cy7 leaks into the QDs7o channel (Figure 3-4(e)). Finally, the blood cells were
80
incubated with QD 612-NB-CD45 and CD45-PE-Cy7. A good correlation between the signal from
CD45-PE-Cy7 and QD 6 12-NB-CD45 was observed, which indicates that the QD 612 conjugated
antibodies label leukocytes specifically (Figure 3-4(f)).
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Figure 3-4 Flow cytometry data on the QDs and the QD conjugates incubated with blood cells
(excluding red blood cells). (a-c) Non-speficic binding test for NB PIL coated QD 612 (QD 612-NB),QD 570-NB and QD 57o-NB-IgG (d) Specific binding of QD 612-NB-CD45 to leukocytes. (e)
Specific binding of CD45-PE-Cy7 to leukocytes. QD 57o-NB-IgG was co-incubated to prove thatQD57o-NB-IgG does not interfere with the labeling of the dye labeled antibodies. (There is some
leakage of PE-Cy7 emission into QD 570 channel) (f) co-incubation of QD 612-NB-CD45 and the
CD45-PE-Cy7 with blood cells. A good correlation between the signal from CD45-PE-Cy7 and
QD6 12-NB-CD45 indicates that the QD612-NB-CD45 specifically label leukocytes in the same
manner as the dye labeled antibodies(CD45-PE-Cy7).
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3.5 In vivo Labeling Experiments
3.5.1 Preparation of the QD-Ab Samples for Vessel Labeling
Following the in vitro labeling experiments, which showed a high degree of specific
binding with very low background, we labeled vessels (meso-scale objects) in live mice with
QD 612-NB-CD31 antibody conjugates (QD 612-NB-CD3 1) and optimized the ratio between QDs
and antibodies to yield the best in-vivo imaging results in terms of the brightness and the stability
of the signal. The immuno-conjugates containing higher number of QDs will provide brighter
signals, but the large size of QDs can initiate undesired bio-pathways in vivo or cause
detachment of QD-Ab conjugates from labeling objects. For this study, samples with three
different ratios of QD and Ab were synthesized by incubating 3:1, 1:1, and 1:3 ratio of QD-NB
to tetrazine modified antibodies. After the synthesis, the QD-Ab conjugates were purified using
gradient centrifugation (Figure 3-5) and the ratio between QD and Ab were measured using BCA
assay (Figure 3-6 and Table 3-3).
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Figure 3-5 Gradient centrifugation to remove free antibodies from the QD 612-CD31 conjugates.
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Figure 3-6 Calibration curve for protein concentration measurement using BSA standard
solution.
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* BSA standard
x QD612:CD31 = 3:1
x QD612:CD31 = 1:1
Table 3-3 Calculation of the actual ratio between QDs and antibodies after purification.
QD6 12:CD31=3:1 QD 612:CD31=1:1
QD612 concentration 0.15 pM 0.21 pM
CD31 concentration in mass 63 gg/mL 204 pg/mL
MW of CD31 150 kDa 150 kDa
Molar concentration of CD31 4.2 x 10- M 1.6 x 10- M
Dilution factor for CD31 10 10
Ratio between QD612 and CD31 3.6: 1 1.3: 1
In addition, the gel filtration chromatograpy (GFC) traces and the transmission electron
microscopy (TEM) images of the resulting QD612-NB-CD31 conjugates showed no aggregate
formation confirming the mono-dispersity of the samples (Figure 3-7 and 3-8).
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Figure 3-7 GFC traces of NB-PIL coated QD 5 70 (solid green line), QD6 1 2 (solid red line), QD800
(solid brown line) and QD-Ab conjugates: QD8oo-IgG (dashed brown line), QD 612-Sca-1 (dashed
red line), QD 570-C-kit (dashed green line).
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Figure 3-8 TEM images of NB-PIL coated QD 612, QD612-CD3 1, Qdot* 625, and Qdot* 625-
CD31 (a) QD6 1 2 in Hexane, (b) NB-PIL coated QD 612, (c) QD612-CD31 conjugates(QD:CD31=1:1), (d) QD 612-CD31 conjugates (QD:CD31=1:1), (e) Qdot* 625, and (f) Qdot*
625-CD31 conjugates. Scale bar = 20nm.
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3.5.2 Vessel Labeling
After the synthesis and the characterization, the QDs or QD conjugates were
administered systemically via retroorbital injection to Tie2GFP/FVB mice and the vessels were
imaged through a mammary fat pad window using a two photon intravital microscope.
Endothelial cells of the Tie2GFP/FVB mice express green fluorescent proteins (GFP) to
visualize vessels; therefore, the specificity of the QD 612-NB-CD31 to endothelial cells can be
confirmed by co-localization of the QD signal to the GFP signal. Before the labeling, non-
specific binding of the QDs and the QD-Ab conjugates was tested in vivo by injecting free
QD 612-NB and QD 612-NB-IgG, and imaging the vessels over time. Both QD 612-NB and QD 612-
NB-IgG completely cleared from the vessels within ~16 hours without leaving any evidence of
non-specific accumulation (Figure 3-9(a-b) and Figure 3-10). In contrast, we observed non-
specific accumulation of the commerical Qdot* 625 and Qdot* 625-IgG in random spots after
the QDs were cleared from the vessels (Figure 3-9(c-d) and Figure 3-11).
86
QDn1 24 hr
QD:CD31=1:1 4hr QDtj:CD31=1:1 24hr
CQdot625 24hr
f
d
QD:CD31=3:1 4hr QD:CD31=31 24hr
Figure 3-9 In vivo imaging (a-d) Non-specific binding studies for a) QD 612, b) QD 612-IgG, c)Qdot* 625 and d) Qdot* 625-IgG. (e-h) Labeling of endothelial cells using the QD612-CD31
conjugates. e) 4 hours and 24 hours after the injection of QD 612-CD31 conjugates with the ratio
of 1:1 for QDs and CD31, f 4 hours and 24 hours after the injection of QD612-CD31 conjugates
with the ratio of 3:1 for QDs and CD3 1.
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Figure 3-10 Time series in vivo imaging of (a) the QD612 and (b) the QD 612-Ab conjugates
(QD 6 ]2-IgG conjugates and the QD 612-CD31 conjugates) at 0, 4 and 24 hours after the injection.
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Figure 3-11 Time series imaging of vessels in live mice after injecting a) the Qdot* 625 and b)
the Qdot* 625-IgG conjugates. Upper 3 panels are for the Qdot* 625 channel only and the lower
3 panels are for both Qdot* 625 and GFP channels.
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Next, the QD 612-NB-CD31 conjugates were injected and their labeling of the vessels was
monitored. As shown in Figure 3-9(e-h) and Figure 3-12, we observed the co-localization of the
QD 612-NB-CD31 signal to the GFP signal of the vessels at 3~4 hours and later time points. After
24 hours the QD signal from the vessels was still visible, but the observed pattern was more
punctate (Figure 3-9(f-h) and Figure 3-12). Punctate patterns indicate endocytosis of the QD 612-
NB-CD31 into endothelial cells due to the relatively large size of the QDs (HD of -13nm)
attached to the antibodies (HD of -12nm). In contrast, allophycocyanin (APC) labeled CD31
(CD3 1 -APC) showed a more diffusive labeling pattern along the vessels up to 24 hours after the
injection (Figure 3-13). Next, the level of labeling by the QD 612-NB-CD31 conjugates was
evaluated at 4 hours and 24 hours after the injection. In both case, the labeling signal was the
highest for the QD:Ab-3:1 sample, and the lowest for the QD:Ab-1:3 sample (Figure 3-9(e-h)
and Figure 3-12).
Next, commercial Qdot* 625 was conjugated with CD31 antibodies using the commercial
antibody conjugation kit (Invitrogen). As shown in Figure 3-14, the vessel walls were well
labeled with the Qdot*-Ab conjugates at 4 hours after the injection but the staining pattern was
more punctate than the pattern obtained with our conjugates. At 24 hours after the injection, only
low intensity of the Qdot* signal was observed and the labeling pattern was much more random
(Figure 3-14). Because of the high nonspecific binding nature of the Qdot® in vivo, we were not
able to distinguish the signal of the Qdot* labeling the vessels from the signal of the Qdot*
nonspecifically accumulated on random bio-compartments at the 24 hour time points.
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Figure 3-12 Time series in vivo imaging of the QD 612-Ab conjugates with different ratios of QD
to Ab.
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Figure 3-13 Time series imaging of vessels of live mice after injecting APC-CD3 1.
Qdot"625-CD31 24hr
Figure 3-14 Time series imaging of vessels in live mice after injecting the Qdot* 625-CD31
conjugates. Upper panel at each time point is for Qdot* 625 channel only and lower panel at each
time point is for both Qdot* 625 and GFP channels.
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3.5.3 Single Hematopoietic Stem Cell Labeling
Finally, single endogenous hematopoietic stem cells (HSCs) were labeled with the QD-
NB-Ab conjugates and Hoechst 33342, and imaged through a chronic bone marrow window.
HSCs were identified by being QD57o-NB-cKit positive, QD612-NB-Sca-1 positive, and Hoechst
33342 negative. QD8oo-NB-IgG conjugates were also co-injected to check the non-specific
binding of the QD-NB-Ab conjugates in vivo. Bones were imaged by second harmonic
generation of collagen; imaging was performed 22-23 hours after the injection of QD-NB-Ab
conjugates. By the time of imaging, unbound QD-NB-Ab conjugates were completely depleted
from the vessels and the bone marrow, and cells in the bone marrow labeled with the QD-NB-Ab
conjugates and Hoechst dyes were visualized (Figure 3-15). The movement of the HSCs and
other cells in the bone marrow was also recorded over 3 hours. More detailed studies on
endogenous HSCs and their microenvironment will be reported elsewhere. Lastly, in order to
prove that the color or the composition of the QDs do not affect the quality of the imaging, we
labeled HSCs using QD-NB-Ab conjugates with different combinations of QDs and antibodies;
QD 8oo-NB-cKit, QD612-NB-Sca-1 and Hoechst33342. In this case, the vessels were visualized
with GFP. Figure 3-16 shows the successful labeling of HSCs which confirms that we can utilize
the variety of QDs that emit in the visible to NIR to prepare the QD-NB-Ab conjugates for
multiplexed imaging.
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Figure 3-15 Hematopoietic stem cell labeling with QD 612-Sca-1, QD 570-cKit, QD8oo-IgG, and
Hoechst33342 in bone marrow.
HSC NBone Marrow Cells NBlood Vessels
Figure 3-16 Hematopoietic stem cell (HSC) labeling using QD8oo-c-Kit, QD612-Sca-1, and
Hoechst 33342 in Tie2GFP/FVB mice.
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3.6 Conclusion
In summary, compact, bright and stable QD-NB-Ab constructs have been synthesized by
taking advantage of recent advances in QD synthesis, ligand development, and conjugation
chemistry on QDs. The high QY and narrow emission feature of the QDs enable simultaneous
imaging of multiple biomarkers, the PIL ligands result in compact size, aqueous stability, and
biocompatiblity, and norbornene-tetrazine click chemistry allow a facile and efficient coupling
antibodies to QDs. Improved transport of the particles owing to the compact size of the QD-NB-
Ab conjugates and extremely low non-specific binding compared to commercially available QD-
Ab conjugates make the QD-NB-Ab a significant step forward for in vivo imaging. In vitro flow
cytometry data indicate that the QD-NB-Ab conjugates specifically label cells in the same
manner as the dye-labeled antibodies, demonstrating a high level of targeting specificity. In vivo
imaging results prove that we can label both mesoscale objects (vessels) and single endogenous
cells in live mice with QD-NB-Ab constructs both in the visible and in the NIR. Especially for
the HSC imaging, five different color channels from the visible to NIR were utilized to label
multiple bio-markers simultaneously. Multiplexing is especially beneficial for in vivo imaging
where diverse cells are present in confined spaces. The technique described here can expand the
scope of in vivo imaging by allowing single endogenous cell imaging in live animals using QDs
of different wavelengths. Further experiments using various QD-NB-Ab conjugates are in
progress to learn more about cellular interactions in vivo in a multiplexed regime. In the next
chapter, we will describe additional HSC labeling experiments that led to new biological
information about the micro-enviroments of the HSCs in live mice.
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3.7 Experimental Section
3.7.1 Synthesis
Synthesis of QDs. QDs used in this study were synthesized with modifications of previously
reported syntheses as described below.
Synthesis of CdSe(CdS) QDs-QDs 70. CdSe cores with a first absorption peak at 480nm were
synthesized using a previously reported method.[3] The cores were precipitated with acetone
three times to remove excess ligands and salts, and left overnight at 40C before overcoating. CdS
shells were deposited on CdSe cores via modification of previously reported procedures. (ref )
Before the shell deposition, the cores (274 nmol) were filtered with a 0.2 p.M PTFE syringe filter
and annealed at 220 'C in a solvent mixture of oleylamine (3 mL) and octadecene (6 mL) until
no spectral shift was observed. Cd and S precursor solutions were then introduced
simultaneously at 240'C over 2 hours. The Cd precursor consisted of 0.3 mmol Cd(oleate) 2 and
0.6 mmol oleylamine in a solvent mixture of octadecene (1.5 mL) and TOP (3 mL). The S
precursor consisted of 0.3 mmol hexamethyldisilathiane [(TMS) 2S] in 6 mL TOP. Addition of a
total of 5 monolayers of CdS yielded QDs with an emission at 570 nm and a quantum yield close
to unity when diluted in octane.
Synthesis of CdSe(Cdo. 3Zno. 7S)-QD 62. The synthesis follows previously reported procedures [28,
37]. The QY of the QD 612 was 50% in octane.
Synthesis of InAs/Cd. 2Zno.8 S-QDoo. Synthesized as previously reported [6]. The quantum yield
of the QDsoo was 20% in octane
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Synthesis of NB-PIL coated QDs (QD-NB). Norbornene modified PIL was synthesized with
modifications of the previous work [30]. (1S,2S,4S)-bicyclo[2.2.1]hept-5-en-2-y acetic acid
(norbomene) was activated by N,N'-Diisopropylcarbodiimide and hydroxybenzotriazole in
anhydrous tetrahydrofuran(THF) at room temperature. The activated norbornene was reacted
with poly(amino-PEG )20%-PIL in dry THF. After the reaction was completed, THF was pulled
off and the reaction mixture was redissolved in water and filtered with a 0.2 pm Tuffryn syringe
filter. The polymer solution was dialyzed 4 times through a 5kDa molecular weight cut off
(MWCO) spin concentrator and redissolved in chloroform for further ligand exchange.
Synthesis of tetrazine modified antibodies (tet-Ab) and QD-Ab conjugates. Amine reactive
tetrazine (5-((4-(1, 2 ,4 ,5-tetrazin-3-yl)benzyl)amino)-5-oxopentanoic acid), which was
synthesized following the previous literature [30, 38], was activated with hydroxybenzotriazole
and N,N'-Diisopropylcarbodiimide in anhydrous N,N-dimethylformamide (DMF) and reacted
with antibodies in pH 7.5 PBS solution overnight at room temperature. 5% DMF was added to
the antibody solutions to solubilize the tetrazine. After the reaction is completed, the tetrazine
modified antibodies (tet-Abs) were dialyzed 4 times using a 50kDa MWCO spin concentrator.
Right after the synthesis of tet-Ab, tet-Ab was mixed with QD-NB for 20-24 hour at room
temperature. After the conjugation, unreacted tetrazine on the antibodies was quenched using 5-
norbornene-2,2-dimethanol. Before the biological experiments, the QD-Ab conjugates were
dialyzed 3 times with a 50kDa MWCO spin concentrator to remove excess 5-norbornene-2,2-
dimethanol.
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3.7.2 Characterization
Fluorescence Correlation Spectroscopy (FCS). Size change of the QD612 and Qdot@ 625
after the serum incubation was measured by FCS using a setup described previously [23]. 1sM
of QD612 and Qdot® 625 were incubated with 90% Fetal Bovine Serum for 4-6 hr at 37'C and
the samples were diluted in PBS right before the measurement. The excitation power was 8 pW
in front of the objective and ten to eleven measurements with acquisition times of 30 s were
performed for each sample. Correlation functions were fit in Matlab (The Mathworks) with the
isotropic 2D translational diffusion model to extract the average particle diffusion times. These
diffusion times were converted to sizes through the Stokes-Einstein equation using the
hydrodynamic radii of the particles in PBS measured by dynamic light scattering as the standard.
Gradient centrifugation. Gradient centrifugation was used to purify free antibodies from the
QD-Ab conjugates. A four layer sucrose gradient (10%+30%+50%+70%) was used for
separation. 0.lmL of QD612-NB or QD612-NB-CD31 samples were added on top of the
multilayer density gradient prior to ultracentrifugation. 0.1mL of DyLigh 649 labeled IgG
(Img/mL, Jackson Immunoresearch) was co-added with the QD samples to visualize the band
for antibodies. The solution was centrifuged at 40krpm (SW32T Rotor, Beckman Coulter.) for 5
hours. After the centrifugation, distinctive bands for antibodies and the QD conjugates were
observed (Supplementary Fig. S2). The QD conjugates were pipetted out and used for BCA
assay measurements to measure the ratio between QDs and antibodies. (Supplementary methods)
Measurement of ratio of QD to Ab in the QD-Ab conjugates using BCA assay. After the
purification of the QDs and QD-Ab conjugates using gradient centrifugation, the QD samples
were dialyzed three times through a 50kDa molecular weight cut off spin concentrator and
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concentrated down to 1 OOgL. The concentration of the QD was then measured using the
absorbance of the QD samples at 350nm and the extinction coefficient of the QD 612.
To measure the concentration of antibodies in QD 612-CD31 conjugates (QD:Ab=3:1 and 1:1),
BCA reagents (Thermo Scientific, Pierce Protein Research Products) (200 pL) were combined
with standard bovine serum albumin solutions (25-2000ug/mL) , QD 612-NB, and QD6i 2-NB-
CD31 samples in triplicate. After reacting the solutions at 37 0C for 30 minutes, absorbance at
562nm was measured. The net absorbance of QD 612-NB-CD31 was calculated by subtracting the
absorbance value of QD 612-NB from that of QD 612-NB-CD3 1. Then, the concentration of CD31
in each QD 612-NB-CD31 samples was obtained by fitting the absorbance value into the standard
concentration vs absorbance curve. The calculated ratio of QD to Ab for QD 612-NB-CD31 (3:1)
and QD 612-NB-CD31 (1:1) was 3.6:1 and 1.3:1 respectively. (Supplementary Table Si)
3.7.3 Flow Cytometry Experiments
For peripheral blood mononuclear cell isolation, blood was harvested by heart punctuation and
red blood cells were lysed by ACK lysing buffer. Cells were then washed twice and resuspended
in 1% BSA in PBS. 1 x 106 lymphocytes were treated with the QDs or the QD-Ab conjugates at a
concentration of 60nM in 1% BSA in PBS at room temperature for 30 minutes. The cells were
washed twice with 1% BSA in PBS and analyzed for fluorescence by flow cytometry.
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3.7.4 In vivo Imaging
Mice preparation. All animal procedures were performed following the guidelines of the Public
Health Service Policy on Humane Care of Laboratory Animals and approved by the Institutional
Animal Care and Use Committee of the Massachusetts General Hospital. Tie2GFP-FVB male or
female mice of 6-8 weeks were obtained from MGH Cox animal facility. Either cranial or
mammary fat pad window model was prepared and used right after wound healing for systemic
injection of QD samples via retroorbital pathway. 50-100 pg of antibodies conjugated to relative
amount of QDs were introduced per injection. For the vessel labeling, imaging was carried out at
multiple time points after the QD-Ab injection and for the HSC labeling experiments, imaging
was performed 20-24 hours after the QD-NB-Ab injection. Due to rapid clearance kinetics of
small molecules, Hoechst 33342 was injected 15 minutes prior to the imaging.
Intravital multiphoton imaging. Two photon images were obtained with a custom-built
multiphoton microscope by using a Ti:Sapphire laser (Mai-Tai Broadband; Spectra-Physics) at
840 or 900 nm, a 20x (0.5 N.A.; Olympus) water-immersion objective, and photon-counting
photomultiplier tubes (H7421-40; Hamamatsu). The laser power was set to 400 mW. Three-
dimensional image stacks were collected containing 21 images of 5 nm thickness and obtained
at emission wavelengths appropriate for the injected particles. A maximum intensity z projection
of each colored stack generated a 2D image. Images of consecutive adjacent regions in the x and
y directions were combined into a montage.
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Chapter 4. Multiplexed Cytometric Immuno Imaging Reveals
Normoxia in Hematopoietic Stem Cell Niche'
4.1 Background and Motivation
As described in the earlier chapters, QDs have numerous advantages over organic dyes as
imaging fluorophores. In this chapter, we demonstrate the applications of QD antibody
conjugates (QD-Ab) in single endogenous cell hematopoietic stem cell (HSC) labeling in the
bone marrow of live mice. Immunomicroscopy imaging in the bone marrow has been previously
performed using antibodies conjugated with organic fluorophores against chemokines and
adhesion molecules [1]. However, the wide emission spectra of fluorophores limit their
multiplexing in vivo. Additionally, the rapid photobleaching of most fluorophores can be
problematic in time lapse imaging. Using QDs overcomes these limitations and allows
multiplexing several specific and non-specific markers, which is critical for cell labeling in vivo
where a variety of cells is present in confined spaces (Figure 4-1). By using QD-Ab, we were
able to label endogenous hematopoietic stem cells and study their microenvironment in live mice,
and that was not possible previously using the dye antibody conjugates.
' This work was done in collaboration with Steele laboratory at Massachusetts General Hospital.
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Figure 4-1 Schematic of in vivo labeling using the multiple QD-Ab conjugates. The purple cell
is labeled with two types of QD-Ab.
The stem cell niche is a highly specialized microenvironment that provides signals for
regulating the asymmetric division of stem cells. These local cues control differentiation into cell
progenies while maintaining a constant source of stem cells. In the bone marrow, all blood cells
are generated by HSCs throughout the lifetime of the organism. While the function of HSC has
been well characterized, the cellular composition and location of the niche in which they reside
have remained elusive due to lack of appropriate methodologies. Previous studies have shown
that HSCs may localize both in endosteal and peri-vascular regions of the bone marrow [2-5].
However, histological techniques commonly used to identify the endogenous HSCs lack the
ability to measure the dynamics or physiology of the niche [2, 4, 5]. On the other hand, available
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intravital microscopy systems can follow cell dynamics, but have not yet succeeded in tracking
endogenous HSCs in the intact marrow. Previous studies have focused on tracking infused HSCs
in pre-irradiated or genetically modified bone marrow [1, 3, 6]. Because of that, the functional
differences and potential cross-talk between the HSCs and the bone marrow microenvironment
in which they reside remain unresolved (reviewed in [7]). For example, the presence of a low
oxygen (hypoxic) environment in the "niche" has been proposed for decades as a key
physiological signal controlling HSC quiescence. Moreover, oxygen gradients are thought to
regulate the direction of HSC differentiation within the niche (reviewed in [8]). However, these
hypotheses have not been directly confirmed due to the lack of ability to directly measure
oxygen gradients in HSC "niches."
In this chapter, we combine newly developed quantum dot (QD) antibody conjugates
(QD-Ab) with a novel chronic bone marrow window preparation to image endogenous HSCs.
This new approach allows us to localize the HSCs and measure the oxygenation in the niche.
4.2 Transvasular Transport within the Bone 1rrow
Prior to using the QD immunocontructs for in vivo cytometry, we characterized the
transvascular transport of macromolecules of comparable sizes within the bone marrow using
previously developed techniques [9]. Analysis of the structure of the bone marrow vasculature
showed the presence of a characteristic sinusoidal capillary network [10]. Direct quantification
of the extravasation rate of macromolecules in these vessels revealed a significant extravasation
of macromolecules as high as MW 500 kDa. To quantify the rate of extravasation of
macromolecules, we performed multiphoton intravital microscopy of the bone marrow before
and at several time points after injection of TAMRA-BSA. We quantified vascular permeability
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at multiple positions along the vessel wall surface using a method previously developed by our
collaborators [9]. BSA extravasated within few minutes and accumulated in the bone marrow
(Figure 4-2). Median permeability was 7.6 [25 percentile = 4.6, 75 percentile = 13.1] x 10~7 cm/s.
These high values are comparable to the permeabilities that were previously measured in tumor
vessels, and are significantly higher than the vascular permeability measured in normal skin or
brain [11-13]. Therefore, we conclude that the bone marrow vessels were highly permeable to
macromolecules (Figure 4-2).
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Figure 4-2 Bone marrow vessels are hyperpermeable to albumin. (A) Representative image of
the bone marrow after injection of rhodamine albumin (TAMRA-BSA - red) in a Actb-GFP
mouse (bone marrow cells are shown in green, and the bone in blue - by SHG) using
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multiphoton intravital microscopy. (B) TAMRA-BSA intensity heat map showing extravasation
of albumin over time which is detectable within 15 and 30 minutes after i.v. injection. (C)
Analysis of vessel permeability. Vessels are segmented and rods are randomly selected in 3D.
BSA accumulation is quantified in each rod. (D) Histogram of permeability quantified along
spots along the vessel wall surface.
4.3 Kinetics of Hoechst33342 Cell Labeling in the Intact Bone Marrow
HSCs express multidrug resistance 1 (MDR1) that inhibits the transport of Hoechst33342
(H33342) dye. Based on this finding, in vitro HSCs-identification assays have been developed to
use H33342 exclusion as a specific stem cell marker [14, 15]. In this study, we used H33342 for
in vivo labeled of HSCs. The in vivo H33342 staining is not only dependent on MDR1
expression but also on H33342 delivery to the bone marrow cells. A recent study used H33342 to
assess the distance to the closest vessel of cells based on H33342 delivery 10 minutes after
injection [16]. In order to reliably use H33342 as a specific negative marker for HSCs in vivo, we
characterized the kinetics of H33342 cell labeling in vivo by imaging cells before and at multiple
time-points after H33342 ranging from 5 to 82 minutes (Figure 4-3). HSCs were identified using
two specific positive markers (c-Kit and Sca-1). Nuclear staining by H33342 was detectable as
soon as 5 minutes after i.v. injection and reached its maximum level within 10-15 minutes in
most cells. This rapid and homogeneous uptake of H33342 indicated that 30 minutes after
H33342 injection, H33342 intensity is not related to its delivery but to its transport in and out of
cells. In most c-Kite Sca-l* cells (>90%), the nuclear staining by H33342 was significantly
dimmer or completely absent when compared to c-Kit- Scal- cells. At the time-points imaged,
the kinetics of uptake of H33342 by HSCs did not show any increase. This suggests that H33342
rate of influx to the cell is slower than that of its rate of efflux. The presence of H33342 dim cells
and negative cells may be related to higher and lower activity of MDR1 in a subset of HSCs.
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This result demonstrated the applicability of H33342 as a specific negative marker for HSCs.
Given the fast uptake of H33342 by bone marrow cells, we imaged analyzed HSCs and bone
marrow cells one hour after H33342 injection.
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Figure 4-3 Kinetics of Hoechst333342 uptake by bone marrow cells. (A) Representative images
of time-lapse multiphoton intravital micrscoscopic imaging of the bone marrow before and after
i.v. injection of Hoechst33342 (H33342). Cell nuclei appear positively stained as soon as 5
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minutes after H33342 injection and reach maximum intensity after 10 minutes. Bone marrow
(BM) cells nuclei uptake H33342 independently of their location relative to bone. (B)
Identification of c-Kit-Sca~- H33342+ cells (i), c-Kite Sca-l H33342'ow cells (ii), and c-Kit* Sea-
1+ H33342- cells (iii) in the bone marrow. (C) Plot of H33342 intensity over time of single cells
collected in two time lapses. H33342 increases within few minutes reaching maximum intensity
in less than 20 minutes. Most c-Kit* Sca-l cells are H33342- ""'.
4.4 Identification of Hematopoietic Stem Cells In vivo
The endogenous HSCs were identified as cells that expressed Sca-i and c-Kit and
excluded the nuclear dye Hoechst33342. Time-lapse imaging showed rapid uptake of the nuclear
dye Hoechst33342 in bone marrow cells but not in c-Kit* Sca-l cells, confirming its HSC
specificity (Figure 4-3). Finally, the bone marrow vasculature was detected using contrast
angiography (circulating QD-immunoconstructs) or transgenic mice selectively expressing GFP
in endothelial cells (Tie2-GFP mice), and the bone was imaged using second harmonic
generation microscopy [3] (Figure 4-4, 4-5, and 4-6).
Figure 4-4 Representative multiphoton microscopy images of a bone marrow cavity with cells
stained using the nuclear dye Hoechst33342 (blue), rat c-Kit-qDot565 (green), rat Sca-1-
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qDot6l2 (red), and rat IgG-qDot800 (gray) antibodies. Bone is imaged using second harmonic
generation (SHG - in gray). HSCs are identified as c-Kite Sca-I + Hoechst33342**/- (arrowhead).
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Figure 4-5 Representative intravital cytometric
Scatter plots of c-Kit vs. Sca-1 and c-Kit vs.
illustrating the thresholds used to define HSCs.
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Figure 4-6 Imaging HSCs in Tie2-GFP mice. Multiphoton intravital images of bone marrow
cavities in a Tie2-GFP mouse. (A) Single color images of Tie2, c-Kit, Sca-1, Hoechst 33342, and
bone. (B) Three-dimensional reconstruction of the bone marrow cavity showing cells (blue),
HSCs (yellow) and blood vessels (red). HSCs were defined as c- Kit+ Scal* Hoechst33342**/-
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4.5 Where Do the HSCs Reside?
4.5.1 Single Vessel Cavities (SVCs) vs Multiple Vessels Cavities (MVCs)
By analyzing the bone marrow vasculature structure, we found that cavities of the
calvarial bone marrow can be classified physiologically into single vessel cavities (SVCs) and
multiple vessels cavities (MVCs). SVCs are characterized by a tube-like structure with one
central vessel surrounded by up to 3 cell layers. MVCs are defined by larger cavities with a more
complex vessel network (see Figure 4-7). The analysis show thatHSCs reside predominantly in
SVCs (12.5 per 1000 cells in SVCs compared to 3.8 per 1000 cells in MVCs; p < 0.05). The
architecture of SVCs is anatomically optimal for HSCs to be in close proximity to vessels and
bone.
HSC Bone Marrow Cells Bone Blood Vessels
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Figure 4-7 Three-dimensional reconstruction of the bone marrow cavity showing bone (gray),
cells (blue), HSCs (yellow) and blood vessels (red). Representative images of single vessel
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cavities (SVCs) and multiple vessels cavities (MVCs) illustrate the density and preferential
localization of HSCs.
4.5.2 Distance from Vessels and Bones
Three-dimensional analysis showed that endogenous HSCs are in close proximity (< 25
gm) to both blood vessels and bone independently of the type of cavity in which they reside
(Figure 4-8). These results suggest that HSCs can interact with vascular and perivascular cells as
well as endosteal cells following the model discussed in review [7] and are consistent with
studies that imaged transplanted HSCs in pre-irradiated animals [3].
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Figure 4-8 Scatter plot of bone marrow cells and HSCs showing their spatial distribution relative
to bone (distance to the closest bone trabeculae) and vessel (distance to the closest vessel).
4.6 Oxygen Level of the HSC "niche"
To assess HSC "niche" oxygenation, we used two-photon phosphorescence lifetime
quenching microscopy [17]. Analysis of bone marrow oxygenation (>9700 measurements, using
4 mice) showed p0 2 measurements that ranged between 20-100 mmHg, and no areas of hypoxia
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(<10 mmHg) (see Figure 4-9 and 4-10). Areas of low oxygen (15<PO2< 2 0 mmHg) encompass
less than 1% of the total measured area. Endosteal P0 2 was variable depending on the position of
the nearest vessel, but was always over 10 mmHg. Specific measurement of p02 within the HSC
niche (bone marrow cavities in which HSCs reside) showed that endogenous HSCs reside in
normoxic areas - in contrast to the widely held view that these niches are hypoxic (Figures 4-10
and 4-11). The niches localized in SVCs were characterized by slightly lower and more
homogenous P0 2 levels as compared to niches in MVCs ( Figure 4-11 D). Mapping PO2 within
SVCs, which are rich in HSCs, showed a characteristic steep gradient decreasing from the central
vessel to the endosteal area. This well-defined gradient seen in SVCs is very different from the
more complex oxygenation distribution in MVCs (Figure 4-10 & 4-1lA-C). To further
characterize the HSC microenvironment, we measured PO2 in the close proximity of HSCs (<
3pm distance). We found that the PO2 in the vicinity of HSCs was not significantly lower than
the average oxygenation of the cavity in which the HSCs resided (Figure 4-11 E). This shows that
HSCs do not preferentially localize in areas with low oxygenation.
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Figure 4-9 Histogram of P0 2 measurements in the bone marrow collected in 1-2 cavities in 4
mice.
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Figure 4-10 P0 2 within HSC niches. Representative images and PO2 maps of bone marrow
cavities in which HSCs are identified. Three-dimensional reconstruction of the bone marrow
cavity showing bone (gray), cells (blue), HSCs (yellow) and blood vessels (red). The green plane
shows the depth at the specific locations where PO2 measurements were performed. Surface plots
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from the central vessel to the endosteal area.
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Figure 4-11 (A) Representative multiphoton microscopy image of a bone marrow cavity with
cells stained with the nuclear dye Hoechst33342 (blue) and HSCs identified by antibodies
against c-Kit (linked with qDot6l2 in red) and ScA-1 (linked with qDot575 in green) and
Hoechst33342 exclusion. HSCs appear yellow with no nuclear staining (white arrow). (B) Three
dimensional reconstruction of the bone marrow cavity showing bone (gray), cells (blue), HSCs
(yellow - white arrow) and blood vessels (red). (C) A surface plot of P0 2 extracted from PO2
measurements using phosphorescence quenching microscopy. PO2 map shows the 02 gradient
within the niche from the central vessel to the endosteal area. (D) Histogram of PO2
measurements performed in HSC niches (bone marrow cavities in which HSCs reside)
comparing single vessel cavities (1784 P0 2 measurements performed in 5 cavities) and multiple
vessels cavities (7575 P0 2 measurements performed in 7 cavities) (n=5 mice). (E) Scatter plot of
HSCs' spatial distribution relative to bone (distance to the closest bone trabeculae) and vessel
(distance to the closest vessel).
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4.7 Imaging of HSCs in the Intact Bone Marrow in Tie2-GFP Transgenic
Mice
In order to image endothelial cells within the bone marrow, we performed bone marrow
intravital microscopy in Tie2-GFP/FVB (Tie2-GFP) mice. Although Tie2 is known to be
specifically expressed by endothelial in most tissues, Tie2 expression was described by several
bone marrow derived cells including Tie2 expressing monocytes [18] and a subset of HSCs [4].
We were able to identify endothelial cells based on Tie2 expression and endothelial cell
morphology. Three-dimensional analysis showed that endogenous HSCs were found in close
proximity to the bone and vessel (Figure 4-6, arrows). As in previous studies, we found that Tie2
expression was not limited to endothelial cells but also included in unidentified bone marrow
cells and a subset of HSCs.
4.8 Conclusion
In summary, we utilized newly developed QD-Ab conjugates and chronic bone marrow
windows to directly image endogenous HSCs in vivo in intact bone marrow niche and probe the
HSC microenvironment. By labeling the endogenous HSCs using the QD-Ab conjugates, we
showed that HSCs localize in close proximity to both blood vessels and bone trabeculae, and
HSCs reside in a normoxic microenvironment characterized by an oxygen gradient between the
endosteal surface and blood vessels. This would not be possible with the traditional methods
using dye conjugated antibodies due to their broad emission profiles and the low two photon
cross sections. It remains to be established whether niches in other tissues, in which the cells
remain local to maintain or reconstitute the anatomy, are also normoxic.
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4.9 Experimental Section
4.9.1 Chronic Bone Marrow Window Preparation
We developed a chronic window model for calvarial bone marrow imaging that allows
imaging the bone marrow over several days. The model is based on the acute preparation model
originally developed by Mazo et al. [19]. In summary, the anesthetized mouse (ketamine 90
mg/kg and xylazine 9 mg/kg) is laid on a rigid plate equipped with a heating pad and its head
shaved. A longitudinal skin incision is made on the skull and the skin is removed. Connective
tissue and periosteum is removed using fine forceps. A coverslip is placed on top of the calvarial
bone and fixed to the bone using glue and plastic powder.
We performed single photon imaging of the bone marrow of Actb-GFP/C57BL/6 (Actb-
GFP) mice and found that bone marrow can be imaged from day 0 and until day 8 without any
inflammation or hemorrhage (Figure 4-12). We performed multiphoton intravital imaging and
found that the bone marrow can be imaged at high resolution and with a penetration depth of
150-200 pm. This penetration depth is sufficient to image bone marrow cavities which are at
around 50 gm depth.
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Figure 4-12 Bone marrow intravital microscopy through the chronic bone marrow window. (A)
Representative single photon image of the bone marrow of a Actb-GFP mouse monitored over a
period of 7 days. The overall vascular network (dark structures) around the central sinus was
readily identifiable and could be imaged over several days with no apparent signs of
inflammation or hemorrhage. (B) Composite image of several fields in the bone marrow using
multiphoton intravital microscopy. Vessels were imaged after injection of angiographic contrast
(TAMRA-Dextran MW 500 kDa injected i.v.). Bone marrow cells were imaged based on the
endogenous expression of GFP under the ubiquitous promoter for cytoskeleton protein p-actin.
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4.9.2 Multiphoton Intravital Imaging Setup and Image Analysis
In vivo multiphoton laser scanning microscopy was performed as previously described [9]
on a custom-built multiphoton laser-scanning microscope using confocal laser-scanning
microscope body (Olympus 300; Optical Analysis Corp.) and a broadband femtosecond laser
source (High Performance MaiTai, Spectra-Physics).
Antibodies. We used c-Kit antibody (CDl 17/c-kit/2B8, BD Bioscience), Sca- 1 antibody (Ly-
6A/E/Sca-1/Purified/El3161.7, BD Bioscience) and non-specific rat IgG. For all antibodies we
injected the 50 pg of antibodies (50 pg based on non-conjugated antibodies) into the animal
retro-orbitally and have imaged 24 hours and 48 hours after injection.
Imaging parameters. In order to multiplex several colors, we used optimal band-pass filters and
different excitation wavelengths. Specifically, qdot565 was imaged using excitation at 840nm
and a 535-100 nm band pass filter; qdot600 was imaged using excitation at 840nm and a 605-50
nm band pass filter; qdot6l2 was imaged using excitation at 840nm and a 610-50 nm band pass
filter; qdot800 was imaged using excitation at 840nm and a 750-100 nm band pass filter;
Hoechst33342 was imaged using excitation at 820-840nm and a 450-50 nm band pass filter;
second harmonic generation (bone) was imaged using excitation at 900nm and a 450-50 nm band
pass filter; Tie2-GFP was imaged using excitation at 900nm and a 535-50 nm band pass filter.
Image analysis. All the image analysis was performed using algorithms developed in-house
implemented on Matlab (Mathworks). Bone was imaged based on second harmonic generation
(SHG) and was digitized using threshold and manual drawing. Vessels were identified by in vivo
staining by antibody infusion or by endogenous GFP expression under the endothelial promoter
Tie2 (in Tie2-GFP mice). The vessels were digitized using thresholding and an active contour
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model as described [20]. Nuclei were imaged using Hoechst33342 dye and segmented using a
recursive threshold method combined with post-processing manual corrections. Distance to bone
and distance to vessel was generated using Matlab distance map function and each cell distance
was measured as the average distance of all its pixels. All 3-D reconstructions were rendered
using Volocity (Improvision Ltd.).
Phosphorescence quenching multiphoton microscopy. We measured p02 in the bone marrow
using phosphorescence quenching multiphoton microscopy(PQM). PQM has been previously
used to measure both vascular and interstitial p02 in vivo [21, 22]. Recently, PQM was adapted
to multiphoton microscopy (MP-PQM), which allows quantification of p02 at high resolution
(~Ipm) and at high depths [17]. In summary, MP-PQM was performed using single photon
counting triggered by the selection of pulses of the excitation source. This technique allows
signal integration (integration time at 6.5s), improves signal to noise ratio, and the result can be
analyzed through fitting a two components lifetime decay model. The MP-PQM system
incorporates a KD*P Pockels cell (Model: 350-50; Conoptics, Inc., Danbury, CT) electro-optic
modulator, an amplifier driver as the temporal gate for pulse selection, and an oscilloscope to
monitor the optical response. The excitation pulses ranged from 1.28 to 15.36 ps in duration
indicating that sample excitation was performed by a train of femtosecond Ti:Saphire laser
pulses ranging in number from 100 to 1230 nm. The laser excitation wavelength used was
1020nm. Photon counting was performed using a multichannel scaler (SR340, SRS, Sunnyvale,
CA) to histogram the counts to 1024 bins. Phosphorescence emission (-690nm) of oxyphorR2
(Oxygen Enterprises, Ltd., Philadelphia PA) was detected using a GaAs photomultiplier tube
(PMT; H7421-50, Hamamatsu, Inc., Bridgewater, NJ). Given the short spectral separation
between the emission wavelength and the excitation wavelength we used a short-pass (<750nm)
122
AR-coated filter. We have also used a 690/90 nm band pass filter to limit noise. Lifetime
measurements were performed by a stationary beam and not in scanning mode.
Physiological monitoring of mice during intravital microscopy. During intravital microscopy
mice were anesthetized using isofluorane (1%-2% in 100% Air) that is known to have minimal
effects on animal baseline physiology [23]. The animal systemic physiology was monitored
during multiphoton intravital imaging by measuring oxygen saturation, heart rate and breathing
rate using a mouse Oxymeter (STARR Life Sciences Corp). Isoflurane levels were adjusted
depending on heart rate and oxygen saturation. When oxygen saturation was lower than 97% for
more than 5 minutes despite adjusting anesthesia, imaging was stopped and the data were
excluded from analysis.
Measurements of oxygenation in the intact bone marrow. We characterized bone marrow
oxygenation by quantifying P0 2 along a grid with a 1 0!m resolution covering 200x200ptm at
three different depths. We have quantified oxygenation in two to three cavities in 5 animals and
have combined all the measurements (9716 measurements) in a pO2 histogram (Figure 4-8). We
detected no areas of hypoxia, and P0 2 ranged between 20-100 mml-Hg. Endosteal P 0 2 varied
depending on the position of the nearest vessel, but was always over 10 mmHg.
P0 2 maps in bone marrow cavities. We measured p0 2 using phosphorescence quenching in
bone marrow cavities where HSCs were identified. Measurements were made in single vessel
cavities and multiple vessels cavities along a grid with 7-15 pm resolution at one to three depths
(Figure 4-9). PO2 distribution in multiple vessel cavities is heterogeneous and correlates with the
complexity of the vessel network. Single vessel cavities have a well-defined 02 gradient going
from the central vessel to the endosteal area.
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Chapter 5. Synthesis of Compact and Biocompatible Quantum
Dots with a Zwitterionic Polymer Coating
5.1 Background and Motivation
In this chapter, we present development of a new class of the QD ligands that
incorporates betaine moieties to synthesize extremely compact and biocompatible QDs.
Poly(ethylene glycol) (PEG) has been one of the most popular surface coatings for nanoparticles
to make them water soluble and non-interactive with biomolecules or cells [1-5]. However, PEG
coatings significantly increase the particles' hydrodynamic size because more than 8 units of
ethylene glycol are required to enable water solubility of the particles. For instance, PEG
coatings produce a hydrodynamic size of > 10nm for an inorganic core/shell of < 5 nm [3, 4].
The small hydrodynamic size of particles is crucial for their access to crowded cellular regions
for biological studies [6, 7], efficient F6rster Resonance Energy Transfer (FRET) [8], and renal
clearance of the particles [9]. Therefore, the search for more compact ligands has been an issue
in the field.
Recently, zwitterionic self-assembled monolayers (SAMs) have brought attention as a
biocompatible surface. Due to the strong hydration capacity via electrostatic interactions,
zwitterionic SAMs show very low nonspecific protein adsorption [10-12]. Small molecules
containing zwitterionic moieties such as cysteine [13], D-penicillamine [14], mercaptoalkane-
phosphorylcho line [15], or dihydrolipoic sulfobetaine ligands [16] have been used to prepare
water soluble QDs or gold nanoparticles. However, those coatings suffer from weak binding of
127
monothiols to the nanoparticles and poor stability of the ligands in ambient conditions owing to
the oxidation of thiols [4].
In this chapter, we demonstrate the development of betaine polyimidazole ligands
(betaine PILs) incorporating pendant imidazole moieties for QD binding and sulfate betaine
(SBPIL) or carboxybetaine (CBPIL) moieties for water-solubilization. Multi-dentate imidazole
moieties provide strong binding of the ligand to the QD surface and prevent aggregation of QDs
[4]. As a result, betaine PIL coated QDs were stable in buffer up to a month as opposed to
several hours or a day for cyesteine. Also, permanent charges on sulfonate and quaternary
amines of SBPIL allow us to synthesize QDs that are zwitterionic at all times as opposed to
zwitterionic molecules containing carboxylic acids and amines whose surface charge depends on
the pH of environments.
Synthesis of betaine PILs was developed by modifying the synthesis of recently
developed PEG containing poly imidazole ligands (PEG PILs) [4], and the betaine PIL coated
QDs (betaine PIL QDs) were prepared by exchanging the native ligand of QDs with betaine PILs.
The resulting QDs were used for in vitro nonspecific cell binding studies, in vivo clearance
studies, trans vascular flux measurements and biodistribution analysis to examine the behaviors
of the betaine QDs in biological environments. In addition, QD-dye conjugates were built by
incorporating derivatizable moieties in SBPILs. With extremely compact size of the betaine PIL
QDs, efficient energy transfer was observed between QDs. In addition, characteristic behaviors
of the betaine PIL QDs were compared with that of the PEG PIL QDs in vitro and in vivo to
learn the influence of zwitterionic ligands on QD behaviors in bio-environments.
128
5.2 Synthesis and Characterization of Betaine PIL QDs
By incorporating multidentate imidazole moieties in the QD ligands, we were able to
synthesize exceptionally stable zwitterionic QDs with shelf life of up to a month. As expected,
the hydrodynamic diameter of the betaine PIL QDs was significantly smaller than that of the
PEGPIL QDs.
5.2.1 Monomer Synthesis and Polymerization
The synthesis of betaine PILs is composed of three steps (Scheme 1): (1) RAFT mediated
polymerization of backbone (Polymer 3), (2) betainization of the polymers (Polymer 4, 6) and (3)
cleavage of BOC protecting groups (Polymer 5, 7). RAFT mediated polymerization allows us
tight control over the mean and standard deviation of the resulting polymer weights, as shown in
the previous literature (Figure 5-lA) [4]. Post-modification of a polymerized backbone to yield
the betaine PILs was chosen as the pre-modified zwitterionic monomer exhibited very limited
solubility in organic solvents.
To prepare the monomer, N-hydroxysuccinimide activated acrylic acid or acryloyl
chloride was coupled to primary amine containing moieties (histamine and N,N-dimethyl
diethane 1,2 diamine) and purified using silica column. The purified monomers were
polymerized via RAFT mediated polymerization using dibenzyl carbonotrithioate as a RAFT
reagent and Azobisisobutyronitrile (AIBN) as an initiator in dry DMF (Scheme 5-1). The
resulting polymer (polymer 3) was used for betainization without further purification. Before the
betainization, the molecular weight and the polydispersity of the polymer samples were
measured by gel permeation chromatography (GPC). As expected, narrow polydispersity and
good control of molecular weight of the polymer 5 was confirmed (Figure 5-lA).
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Figure 5-1. Characterization of (A) polymer 4 by gel permeation chromatography and (B)
polymer 5 by gel filtration chromatography.
For betainization, highly strained 1,3-sultone and p-propiolactone were used. Release of
ring strain allows one-step conversion of tertiary amine to quatanary amine and either sulfonate
(sulfobetaine PIL (SBPIL), Polymer 5) or carboxylate group (carboxybetaine PIL (CBPIL),
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Polymer 7). Before the betainization, compatibility of 1,3-sultone with BOC protected amines
was verified by mixing 1,3-sultone with monomer 2 and monomer 8 and monitoring the NMR
spectra since 1,3-sultone is known to form highly acidic solutions in the presence of water which
in turn deprotect the BOC groups. The NMR spectra confirmed that the BOC groups on
monomer 2 and 8 are intact after incubation with 1,3-sultone (Figure 5-2). For the betainization,
2-(dimethylamino)ethyl acrylate homopolymer (Scheme 5-2, polymer 9) was used as a model
polymer to optimize the chemistry to achieve the conversion yield of close to unity. The
conversion efficiency was measured by elemental analysis of the resulting betaine polymer
(polymer 10 in Scheme 5-2, refer to Table 1 for the elemental analysis data done by Atlantic
Micro Lab Inc.). The extent of the betainization measured by H NMR was not accurate since
peak broadening of the polymers hinders accurate integration of each peak (Figure 5-3). Before
the betainization, polymer 3 was soluble in a wide range of organic solvents such as chloroform,
methanol, and dimethylformaide. However, after the betainization, the polymers were only
soluble in aqueous solution or highly fluorinated organic solvents such as 2,2,2-trifluoroethanol
and 1,1,1,3,3,3-hexafluoropropan-2ol. The size of the final polymers was measured using gel
filtration chromatography (GFC) against protein standards (BioRad) (Figure 5-1B). The narrow
molecular mass distribution of polymer 3 was preserved after the betainization, which indicates
high conversion efficiencies of the tertiary amine moieties to betaines. The lower molecular
weight of the final polymer (polymer 5, 7), which is calculated from the hydrodynamic size,
compared to the polymer before betainization (polymer 3) might be due to differences between
the hydrodynamic volume of betaine PILs and the standard proteins (Vitamin B12, Myoglobin,
Ovalbumin, and Gamma Globulin).
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Figure 5-2 Compatibility of 1,3-sultone with BOC protected amine containing monomers. NMR
spectra of (A) monomer 2, (B) monomer 2 mixed with 5 times excess of 1,3-sultone, (C)
monomer 8, and (D) monomer 8 mixed with 5 times excess of 1,3-sultone.
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5.2.2 Preparation of Betaine PIL QDs
Water soluble QDs coated with the betaine PIL were prepared by ligand exchange of the
native hydrophobic ligand capped QDs with the betaine polymers. InAs(CdxZniS) emitting at
800 nm, CdSe(CdS) emitting at 570 nm and CdSe(CdZnS) emitting at 605 nm were successfully
brought into water by exchanging their native ligands with SBPILs and CBPILs. This experiment
confirms that the betaine polymers can be used for water solubilization of various type of QDs
ranging from visible to near infrared. The ligand exchange was achieved using a modified
biphasic exchange method. In a typical biphasic exchange, QDs are dissolved in a hydrophobic
solvent such as chloroform and stirred with the water layer containing water-soluble ligands [13].
However, this method requires a concentrated solution of ligands and does not work for
polymeric ligands with multidentate binding units; This is because simultaneous coordination of
binding units is difficult to achieve at the interface of hydrophobic and hydrophilic solvents.
Therefore, we first performed partial ligand exchange by adding the betaine polymer solution
dissolved in 2,2,2-trifluoroethanol, and then performed biphasic ligand exchange. While adding
the polymer solution, the QD solution becomes turbid due to low solubility of the QDs in 2,2,2-
trifluoroethanol. The resulting QD solution was not soluble either in chloroform or in water,
which indicates partial exchange of the native ligands. After that, chloroform and water were
added to the QD solution and the whole solution was stirred vigorously. Within 1 minute, QDs
were transferred to the water phase leaving the chloroform phase transparent (Figure 5-4). This
result can be explained by the increased solubility of QDs in aqueous solution after the partial
ligand exchange, which in turn promotes the complete exchange of the native ligands with the
betaine PILs via biphasic ligand exchange.
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Figure 5-4 Modified biphasic ligand exchange. After the exchange, the SBPIL QDs were well
dispersed in aqueous solutions. Left panel shows the picture taken under the room light and right
panel shows the picture take under UV illumination.
5.2.3 Characterization of the Betaine PIL QDs
After the ligand exchange, both SBPIL QDs and CBPIL QDs were well dispersed in
aqueous buffers with pH ranging from 5 to 12. Transmission electron microscopy (TEM) images
confirmed that both CBPIL and SBPIL QDs are monodisperse without forming aggregates
(Figure 5-5). Both QD solutions were stable in buffers for over a month under ambient
conditions, which is a great enhancement from the zwitterionic ligand coated QDs presented in
previous literature that have shelf lives of several hours to a day at the most (data not shown).
After ligand exchange, a slight red shift of the emission peak (2-3 nm) of the betaine PIL
QDs was observed but the full width half max of the emission features remained fairly constant.
Absorbance and emission spectra of CdSe(CdS) before and after the ligand exchange with the
SBPILs are shown in Figure 5-6A. The quantum yield (QY) of CdSe/CdS coated with the
betaine PIL was -65%, a modest drop from a QY of >90% in n-octane with native ligands. The
PEG PIL QDs showed slightly higher QY (-80 %) than betaine PIL QDs (-65%). This may be
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due to better passivation of the QD surface with the PEG PILs than betaine PILs owing to the
long repeating units of ethylene glycol. In addition, photo-brightening of the betaine PIL QDs
after UV treatment was observed as reported previously for the PEG PIL QDs [4].
(A) (B) (C)
Figure 5-5 TEM images of (A) QD 612 in hexane, (B) CBPIL QD 61 2 , and (C) SBPIL QD 612 .
The hydrodynamic size of the SBPIL QDs, which was measured with both GFC and
dynamic light scattering (DLS), was significantly smaller (-7nm) than that of the PEG PIL QDs
(- 11nm) (Figure 5-6B). GFC traces were taken only for the SBPIL QDs as the CBPIL QDs
showed strong interaction with the GFC media which prevented the elution of the particles.
However, DLS data showed the hydrodynamic size of the CBPIL QDs is very similar to that of
the SBPIL QDs (Figure 5-6B). The small size of the QD constructs is beneficial for sensing
applications based on energy transfer and for the access of the QD constructs to biologically
crowded regions such as neuronal synapses or solid tumors. In addition, in vivo studies have
shown that the small size promotes rapid clearance of QDs via urinary excretion as intact
nanoparticles, and minimizes the toxicity of QDs in live animals [9].
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Figure 5-6 Characterization of the betaine PILs QDs (A) Absorption (sold black and dashed blue)
and Emission (solid red and dashed green) spectra of QDs before (dashed) and after (solid)
ligand exchange with SBPILs. (B) Dynamic scattering data of SBPIL QDs, CBPIL QDs and
PEGPIL QDs. (C) Zeta potential measurements for the SBPIL and CBPIL QDs (D) Gel
electrophoresis of the PEGPIL QDs (first lane), SBPIL QDs (second lane), CBPIL QDs (third
lane) and DHLA QDs (fourth lane).
The surface charges of SBPIL coated QDs and CBPILs coated QDs were characterized
by measuring the zeta potential and performing gel electrophoresis. The zeta potential of the
CBPIL QDs was - 0.3mV (close to neutral) and that of the SBPIL QDs was - -13. 1mV (mildly
negatively charged) (Figure 5-6C). This data is consistent with gel electrophoresis results where
CBPIL QDs did not move when applying the voltage, while SBPIL QDs moved slightly towards
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the positive electrode (Figure 5-6D). The PEG PIL QDs, which are almost neutral, and
dihydrolipoic acid (DHLA) coated QDs, which are highly negatively charged, were run with the
betaine PIL QDs as a reference. The negative surface charge of the SBPIL QDs despite the
zwitteronic nature of the SBPILs can be explained by the association of negative ions present in
buffers with the quaternary amines in the SBPILs. The quaternary amines and the carboxylate
groups of the SBPILs are separated by three carbons, which provide an enough space for a
negative ion to be associated with the amine. In contrast, the quaternary amines and the
carboxylate groups of the CBPILs are separated by only two carbons. Due to the proximity of the
negative and the positive groups, hydration shells around two groups generate more spatially
uniform and stronger hydration layer, which result in the neutral surface charge of the CBPIL
QDs [12].
5.2.4 Non-biocompatible Behaviors of the CBPIL QDs
Even though both CBPILs and SBPILs were successful at solubilizing QDs in aqueous
buffers, CBPIL QDs exhibited strong interaction with sugar-based polymeric beads such as
sephadex, superdex, and superose, and also showed high nonspecific binding towards cells. This
observation contradicts what has been reported previously. Several papers reported that self-
assemble monolayers displaying carboxybetaine moieties exhibit extremely low nonspecific
binding properties [12, 17-20]. This discrepancy can be explained by the usage of different
substrates. Most of the previous experiments were executed on gold surfaces with
carboxybetaine ligands possessing thiols as a coordinating group. In this case, the binding
constant between thiol and gold is far greater than the binding constant between carboxylate and
gold[21-23], and all carboxylate groups are exposed to the environment rather than binding to
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the gold surface. But in case of the CBPIL QDs, the binding energy of carboxylic acids with the
QD surface is similar to that of amines [24]. Therefore, in case of the CBPIL QDs, we expect
both carboxylic acids and imidazole moieties to bind to the QD surface. Attraction of
carboxylate groups towards the QD surface has been confirmed by low conjugation efficiencies
of the carboxylic groups on the QDs [4, 25]. For the CBPIL QDs, binding of carboxylic acid to
the QD surface will result in the exposure of positively charged quaternary amines to the
outermost layer of the QDs. The exposed quaternary amine groups of the CBPILs can trigger
nonspecific interaction of the CBPIL QDs with cells and the polymer beads. In contrast, the
sulfonate groups of the SBPILs do not interact with the QD surface and allow the entire
sulfobetaine moieties of the SBPIL QDs to face outward. With the limited biocompatibility of
the CBPIL QDs, we used only SBPIL QDs for in vitro and in vivo studies.
5.3 Functionalization of SBPIL QDs and Conjugation of Bio-Molecules
5.3.1 Conjugation to an Organic Dye for Forster Resonance Energy Transfer
To provide the derivatizability to the SBPIL ligands, we incorporated 10% of amino-
PEG 3 acrylamide to the SBPILs (polymer 12) and modified the primary amine groups with
norbornene to yield norbomene containing SBPILs (NBIO%-SBPILs, polymer 13, Scheme 5-3).
Amine groups were converted to norbornene groups since the positive charge of amine groups in
the PIL ligands increases the nonspecific binding of the PIL QDs to cells and proteins [3, 4].
After the ligand preparations, NB-SBPIL QDs were prepared by the ligands exchange process as
described earlier. To conjugate organic dyes to NB1 o%-SBPIL QDs, norbornene modified QDs
were mixed with tetrazine modified Alexa594. Sixteen hours after the incubation of NBio%-
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SBPIL QDs with tetrazine modified Alexa594, unreacted dyes and byproducts were purified
with GFC and spin concentrator with molecular weight cut off (MWCO) of 50 kDa. Refer to the
method section for more detailed synthesis.
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Figure 5-7 (A) Absorbance and (B) emission spectra of the QD-Alexa594. The conjugation was
achieved by mixing tetrazine modified Alexa594 (Alexa-BAT) with norbornene modified SBPIL
QDs and purified unreacted Alexa594 using GFC and spin concentrators.
Absorbance spectra of the QD samples after the conjugation exhibit both features from
the dye and the QDs which confirms successful coupling of the dyes to QDs (Figure 5-7). Figure
4B shows the emission spectrum of the conjugates under 400nm excitation where the dye has
minimal absorbance. Under this circumstance, only QDs are excited by the direct excitations and
the dyes can be excited through F6rster Resonance Energy Transfer (FRET) from the QDs. As
expected, the QD emission was significantly quenched compared to the control QDs processed
similarly but without the dyes, while the dye emission was enhanced more than 70 times
compared to the free dyes of the same concentration which were excited at 400nm. The emission
spectra show that we were able to achieve efficient FRET from QD to the dye even with the
142
small number of dyes conjugated per QD (-1.4 dye/QD) owing to exceptionally small
hydrodynamic diameter of the SBPIL QDs.
5.4 In vitro Experiments Using SBPIL QDs
5.4.1 Nonspecific Binding to HeLa Cells
To evaluate the suitability of SBPIL QDs as bio-imaging probes, nonspecific adsorption
of the SBPIL QDs to cells was investigated by incubating the SBPIL QDs with HeLa cells and
subsequently washing the cells four times with phosphate buffered saline (PBS). The cell
experiments showed dramatic difference in nonspecific cell binding depending on the
betainization efficiencies of the SBPILs (Table 5-1).
Table 5-1 SBPIL samples that were synthesized with different ratios of the tertiary amines to
1,3-sultone for betainization and the properties of the QDs coated with each SBPIL sample.
SBPIL sample 1 SBPIL sample 2 SBPIL sample 3
30 amine: sultone 3" amine : Sulton 30amine : Sulton
1 :1.2 =1 :3 = 1 :5
Elemental analysis 2.424 ---- 1.919
(S to N Ratio) (82.5% conversion) (104.2% conversion)
Nonspecific binding to Significant binding Less binding than No binding
cells sample 1
Zeta Potential -0.4mV -10.3mV -13.1 mV
As shown in Figure 5-8, Cells incubated with QDs coated with SBPIL sample 1, the
polymer with 80% conversion of tertiary amines to sulfobetaines, exhibited significant increase
of fluorescence signal indicating nonspecific binding of the QDs to cells. On the other hands, the
cells incubated with QDs coated with SBPIL sample 3, the polymer with 100% conversion of the
tertiary amines to sulfobetaines, showed minimal increase of fluorescence signal. This result
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confirms that even a small number of positively charged amines induces high nonspecific
interaction of the particles with cells. After we confirmed that 100% conversion of the tertiary
amines to sulfobetaines is crucial to prepare SBPIL QDs with minimal nonspecific adsorption to
cells, we compared nonspecific binding of the SBPIL QDs with that of the PEGPIL QDs to
understand the influence of the betaine moieties to the biocompatibility of the particles in vitro.
At the concentrations of 50nM or lower, both the SBPIL QDs and the PEGPIL QDs showed
nearly no binding (Figure 5-9). However, when the cells were incubated with the SBPIL QDs at
the concentrations above 1OOnM, the SBPIL QDs exhibited slightly higher nonspecific
adsorption to the cells than the PEGPIL QDs of the same concentration. This result is likely due
to better passivation of the QD surface with PEG that has long repeating units of ethylene glycol
(n > 11). We expect that long and flexible PEG chains physically protect the QD surface, and
prevent proteins or bio-compartments from being adsorbed.
(A) 3"amine:sultone = 1:1.2 (B) 3"amine:sultone = 1:3 (C
Figure 5-8 Nonspecific binding of the SBPIL QDs on HeLa cells with incubation at 100 nM QD
concentration for 5 minutes at 4 *C, followed by 4 times wash with PBS buffer before imaging.
(A) QDs coated with SBPIL sample 1, (B) QDs coated with SBPIL sample 2, and (C) QDs
coated with SBPIL sample3. Significant decrease of the nonspecific binding was observed as the
betainization efficiencies increases from 80% to 100%.
144
(A) 50nM PEG PIL QDs
Figure 5-9 Nonspecific cell binding test with (B) 50nM of the PEGPIL QDs and (C) the SBPIL
QDs. Both (B) and (C) showed the similar fluorescence level as the auto fluorescence of the cells
(A).
5.5 In vivo Experiments Using SBPIL QDs
5.5.1 Nonspecific Binding to Serum Proteins for In vivo Applications
Since betaine SAMs, betaine polymer coated silica particles and gold nanoparticles have
shown very low nonspecific adsorption of proteins in the previous studies [10-12, 18], we expect
betaine PIL QDs to display very low bio-fouling properties. To illustrate the stability of the QDs
for in vivo experiments, we incubated the SBPIL QDs with different concentrations of fetal
bovine serum (FBS) (0.2x, 0.5x and 0.95x FBS) for 4 hours at 370C, and verified the size change
of the QDs before and after the incubation using size exclusion chromatography with
fluorescence detection. The QDs incubated with PBS were used as the control. GFC traces show
that the peak position of the SBPIL QDs did not change after serum incubation which indicates
negligible nonspecific protein adsorption (Figure 5-10). However, we observed the growth of a
small peak on the left shoulder of the elution spectra as we increased the concentration of FBS.
This suggests that nonspecific binding does scale with protein concentration. Notwithstanding,
the SBPIL QDs are still promising probes for in vivo imaging since they have extremely low
protein adsorption properties when incubated with 50% FBS. Considering that blood is
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(C)Auto fluorescence 50nM SBPIL QDs
composed of 50% serum and 50% blood cells, we expect the SBPIL QDs to be biocompatible in
vivo.
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Figure 5-10 Nonspecific binding of QDs with serum proteins after incubation 20% (red), 50%
(green), and 95% (blue) fetal bovine serum for 4 hours at 37 *C. QDs in PBS (black) and 100%
FBS were run as a control.
5.5.2 In vivo Behaviors of SBPIL QDs
With low nonspecific serum binding, greatly enhanced stability and exceptionally
compact size, the SBPIL QDs are expected to be excellent probes for in vivo imaging. To study
the behaviors of the SBPIL QDs in vivo, we have carried out clearance studies, transvascular flux
measurements and biodistribution studies. First, we examined clearance behavior of the SBPIL
QDs in vivo by injecting Inmol of SBPIL QDs (100uL of lOnM QD solution) via retro-orbital
route in live mice and imaged vessels over time. As seen in Figure 5-11, we observed that the
SBPIL QDs cleared from the vessels without leaving any evidence of nonspecific accumulation
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of the QDs. This result was consistent among different core/shell QDs ranging from visible to
near infrared (CdSe/ZnS, CdSe/CdZnS, CdSe/CdS, and InAs/CdZnS) (data not shown).
(A) (B) (C)
Figure 5-11 Clearance of the SBPIL QD612 from the vessels. The vessels were imaged through a
mammary fat pad window at (A) 15 minutes, (B) 60 minutes, and (C) 4 hours after the injection.
Note that SBPIL QD 612 clears from the vessels without leaving any evidence of nonspecific
accumulation. Scale bar = 100 pm.
After confirming that the SBPIL QDs showed virtually no nonspecific binding in vivo,
clearance kinetics of SBPIL QDs versus PEGPIL QDs were compared to verify the effect of the
betaine moieties on in vivo behavior of the QDs. For comparison, PEGPIL QD5 7o and SBPIL
QD 612 were coinjected into live mice and their clearance from vessels was imaged at multiple
time points. PEGPIL QD5 70 and SBPIL QD612 have similar hydrodynamic sizes (~10nm, Figure
5-12), therefore, we were able to eliminate the effect of the size difference on their characteristic
in vivo behaviors. Even though they have similar hydrodynamic diameters and similar zeta
potentials (-7.7 mV for PEGPIL QD5 7o, -13.1mV for SBPIL QD 612), they showed very different
clearance behaviors. Surprisingly, the SBPIL QD 612 cleared much more quickly than the PEGPIL
QD5 70 as shown in Figure 8 and Figure 5-13A. We confirmed that this result is solely due to the
difference in the coatings and not due to the variability of the core QDs by comparing the
clearance behavior of SBPIL QDs versus PEGPIL QDs that were prepared with the same core;
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QD7 5 0 (InAs/CdZnS, Figure 5-13B). Higher level of nonspecific serum binding of the SBPIL
QDs compared to the PEGPIL QDs might cause much more rapid clearance of the SBPIL QDs.
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Figure 5-12 GFC traces of PEGPIL QD5 70 and SBPIL QD612.
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Figure 5-13 Comparison of clearance kinetic of SBPIL QDs versus PEGPIL QDs. (A) Clearance
kinetic of SBPIL QD 612 and PEGPIL QD 570, which have very similar hydrodynamic diameters.
(B) Clearance kinetic of SBPIL QD 750 and PEGPIL QD 750 that were synthesized with the same
QD cores.
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After the clearance study, we measured the transvascular flux of the SBPIL QDs, a
measure of how fast QDs extravasate from vessels. Transvascular flux of the QDs was measured
in two different types of breast tumor which have different pore sizes; E0771 and MCaIV.
MCaIV has exceptionally larger pores than other tumors (pore cutoff size of 1.2 to 2 pm while
most tumors show pore cutoff size of 380 to 780 nm) [26, 27]. For this study, we injected SBPIL
QD612 into mice bearing the tumors and measured the level of QD signal outside the vessels over
time.
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Figure 5-14 (A-B) Real-time intravital microscopy of ligand-dependent nanoparticle distribution
in a murine breast tumor. Intravenous injection into a SCID mouse bearing an E0771 murine
mammary adenocarcinoma in a mammary fat pad chamber of a mixture of (A) SBPIL QD612 and
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(B)PEGPIL QD 570. Angiographic images demonstrate distribution of the nanoparticles one hour
after injection. The initial fluorescence was recorded shortly after injection, and is depicted as the
gray line. Images are mean intensity projections of 3D volumes. Scale bar is 100 pm. (C-D)
Transvascular flux of SBPIL QD5 70 and PEGPIL QD6 12 in mice bearing an E0771 murine
mammary adenocarcinoma and a MCaIV breast mammary cancer. (C) illustrates transvascular
flux measured in individual mice. Solid lines are the values obtained from the mice bearing
MCaIV tumor and dashed lines are the values obtained from the mice bearing E0771 tumor. (D)
illustrates the average transvascular flux and the standard deviation.
Transvascular flux was calculated using the equation presented in the previous paper [28].
In both tumor models, the SBPIL QD6 12 showed 1 order of magnitude less transvascular flux
than that of the PEGPIL QD5 70 (Figure 5-14). The difference of the transvascular flux between
the SBPIL QDs and the PEGPIL QDs was less significant for the MCaIV tumor model which
has larger pores. The significantly low transvascular flux of the SBPIL QDs can be explained by
the reduced circulation half-life and weak negative charge of the SBPIL QDs. As shown in
Figure 5-13A, only 35% of SBPIL QDs were present in the vessels 105 minutes after the
injection while 76% of PEGPIL QDs remained in the vessels at the same time point. Due the
reduction of the circulation time, the SBPIL QDs are thought not to have enough time to leave
the vessels and enter the vicinity tissues. Also, the negative charge of the SBPIL QDs can cause
repelling of the QDs from endothelial cells, which are known to display negative charges on the
surface, which in turn hinder extravasation of the QDs [29, 30]. With low transvascular flux,
SBPIL QDs will be useful for tracing vasculature more effectively than PEG displaying QDs
because they do not leave the vasculature or raise the background signal.
Lastly, we performed in vivo biodistribution studies to unravel the cause of the fast
clearance of SBPIL QDs. To investigate the biodistribution and tumor accumulation of the
SBPIL QDs, the amount of cadmium delivered to various organs was measured using inductively
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coupled plasma mass spectroscopy (ICP-MS) 24 hours after the SBPIL QD612 injection. To
prepare the organ samples for the measurements, organs were collected from mice, physically
homogenized using a homogenizer and boiled in concentrated nitric acid at 120*C for three days.
After 3 days, all the organs were completely dissolved and the solutions became transparent.
Then, the concentrated nitric acid was evaporated and 2% nitric acid with Ippb In was added to
produce the final organ samples for the measurements. To calculate the amount of cadmium
delivered to each organ, we first generated the calibration curve using a series of cadmium
solutions of known concentrations. After that, net increase of the cadmium level was obtained by
subtracting the cadmium level, which is reported as counts, of the control mice from that of the
QD injected mice. The net counts were then converted into cadmium concentrations by fitting
them on the calibration curve. As seen in Figure 5-15, -70% of SBPIL QDs were cleared
through liver and spleen which implies RES clearance of the particles.
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Figure 5-15 Bio distribution study of the SBPIL QDs 24 hours after the QD injection.
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5.6 Conclusion
We developed a new class of polyimidazole ligands incorporating imidazole moieties for
QD binding, and sulfobetaine or carboxybetaine moieties to provide water solubility and
biocompatibility. Compared to traditionally used PEG composed of long repeating units of
ethylene glycol, the betaine moieties of the SBPILs produce extremely compact size QDs while
maintaining biocompatible behaviors. When the same size inorganic core/shell QDs were used,
the betaine PIL QDs were 3.5 nm smaller in hydrodynamic diameter than the PEG PIL QDs. In
addition to the small size, the strong hydration capacity of the betaine polymers via electrostatic
interaction yields extremely low interaction of the SBPIL QDs with bio-environments.
Nonspecific cell binding studies and nonspecific serum binding studies show that the SBPIL
QDs exhibit extremely low nonspecific interaction with cells and the serum proteins. Next,
biological behaviors of the SBPIL QDs were compared with that of the PEGPIL QDs to
demonstrate the influence of the sulfobetaine moieties to the QD performance in vivo and in vitro.
Both in vitro and in vivo studies confirm that PEG moieties are better at passivating the QD
surface and repel proteins or cells from being adsorbed nonspecifically. This property of the PEG
likely comes from the long and flexible nature of the PEG. We expect PEG groups on QDs exist
as partially folded forms and wrap around the QD surface to physically protect the QDs. Even
though PEGPIL QDs showed more stealthy nature, the SBPIL QDs also exhibited extremely low
nonspecific interaction with biomolecules under optimized conditions and allowed us to perform
in vitro targeting and in vivo vessel imaging studies with minimal background. Combining
extraordinarily compact and biocompatible properties of the SBPIL QDs with other general
properties of PIL QDs such as high QY, enhanced stability due to multidentate binding of poly
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imidazole motif to QD surface and facile derivatizability, the SBPIL QDs can be widely used in
biological studies well beyond the examples provided in the text.
5.7 Experimental Section
5.7.1 Materials and Instrumentation
All chemicals were purchased from Sigma Aldrich unless noted and were used as
received. Alexa Fluor@ 594 carboxylic acid, succinimidyl ester was purchased from Invitrogen.
(1 S,2S,4S)-bicyclo[2.2.1]hept-5-en-2-yl acetic acid was purchased from ChemBridge. All
solvents were of reagent grade or higher and were used without further purification. All air
sensitive materials were handled in an Omni-Lab VAC glove box under dry nitrogen atmosphere
with oxygen levels < 0.2 ppm. All solvents were spectrophotometric grade and purchased from
EMD Biosciences. All UV/vis spectra were recorded on an Agilent 8453 diode array UV/vis
spectrophotometer. Photoluminescence and absorbance spectra were recorded with a BioTek
Synergy 4 Microplate Reader. Flash column chromatography was performed on a Teledyne Isco
CombiFlash Companion. Polymer molecular weights were determined in DMF solutions on an
Agilent 1100 series HPLC/GPC system with three PLgel columns (103, 104, 105 A) in series
against narrow polystyrene standards. Molecular weights of polymers after betainization were
determined in DMF solutions on an AKTAprime Plus chromatography system from Amersham
Biosciences equipped with a self-packed Superose 12 10/300 column against BioRad Gel
filtration standards. Dynamic light scattering analysis and zetapotential measurements were
performed on a Malvern Instruments ZetaSizer ZS90 in a 45 VL plastic cuvette. 1H NMR spectra
were recorded on a Varian Inova 500 NMR Spectrometer.
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5.7.2 Synthesis
Synthesis of Monomers. Compound 1. N,N-dimethyl ethylene diamine (3.17g, 36 mmol) was
added to an anhydrous THF (60mL) at 4"C. To this solution, acryloyl chloride (2.70g, 30 mmol)
was injected slowly which is followed by addition of triehylamine (3.64g, 36 mmol). The
solution was warmed to room temperature and stirred for 2 h. Precipitates were removed by
filtration, and the solvent was evaporated in vacuo. Ethylacetate (50 mL) was added to facilitate
further precipitation of reaction byproducts, and the solution was filtered once more. The crude
product was purified by silica column (ethyl acetate/hexanes gradient 50:50 to 100:0, v/v) to give
the pure product as a clear oil (2.59 g, 72% yield). 1H NMR (400 MHz, CDCl3): 6 (ppm) 6.19
(dd, JI ) 1.8 Hz, J2 = 17.0 Hz, 1H), 6.07 (dd, J1= 9.8 Hz, J2 = 17.0 Hz, 1H), 5.53 (dd, Ji = 1.8
Hz, J2 = 10.0 Hz, 1H), 3.38(dt, JI= 5.6 Hz, J2 = 5.6 Hz, 2H), 2.41 (t, 2H), 2.20 (s, 6H).
Compound 2 and 3 were synthesized as described in previous literature [4].
Typical Synthesis of Betaine PILs. All monomers were kept as dilute stock solutions between
30-100 mg/mL in ethylacetate. Stock solutions of RAFT agent (using dibenzyl carbonotrithioate)
were prepared at 220 mg/mL in DMF, and AIBN was prepared at 50 mg/mL in DMF. All
reagents were weighed out volumetrically. In a typical polymerization, monomers 1 (35.5 mg,
0.25 mmol) and 3 (66.3 mg, 0.25 mmol) were added to an 8 mL vial. The solvent was removed
in vacuo and 50 uL of dry DMF along with RAFT agent (2.63 mg, 0.0125 mmol), and AIBN
(2.05 mg, 0.0125 mmol) were added. The contents of the vial were mixed, centrifuged at 5000
xg for 2 min, and then transferred to a 1 mL ampule. The ampule was subjected to 4 cycles of
freeze-pump-thaw, and sealed under vacuum using a butane torch. The vial was heated to 70 'C
154
on an oil bath for 3.5 h. Aliquot of the polymer solution was analyzed using GPC to determine
molecular weight and poly dispersity. After confirming the polymerization is complete, the
polymer solution was transferred to a 8mL vial and DMF was pulled off by vacuum, which was
followed by addition of anhydrous THF (2mL) and 5 times excess of 1,3-propane sultone
(152.7mg, 1.25 mmol) or p-propiolactone (108.2 mg, 1.25 mmol). Gelation occurred within 6
hours but the reaction solution was stirred 24 hours at room temperature. The pellet was washed
with THF three more times to remove unreactedl,3-propanesultone or P-propiolactone. THF was
removed in vacuo and 0.5 mL of a 4 M HCl in MeOH solution was added to cleave the BOC
protecting groups. After 1 h at RT, the HCl was removed in vacuo. The deprotected polymer was
dissolved in MeOH, to which a solution of NaOH in H 20 (5 M) was added dropwise to adjust
the pH to be between 9 and 10. The solvent was removed in vacuo, and then 2,2,2-
trifluoroethanol was added to precipitate the salts. The solution was filtered through a 0.45 Um
PTFE filter and the solvent removed in vacuo to yield the final polymer for QD ligand exchange.
Synthesis of QDs. QDs used in this study were synthesized with modifications of previously
reported syntheses as described below.
Synthesis of CdSe(CdS) QDs-QDs57 0 CdSe cores with a first absorption peak at 480nm were
synthesized using a previously reported method [31]. The cores were precipitated with acetone
three times to remove excess ligands and salts, and left overnight at 40 C before overcoating. CdS
shells were deposited on CdSe cores via modification of previously reported procedures [4].
Before the shell deposition, the cores (274 nmol) were filtered with a 0.2 pM PTFE syringe filter
and annealed at 220 'C in a solvent mixture of oleylamine (3 mL) and octadecene (6 mL) until
no spectral shift was observed. Cd and S precursor solutions were then introduced
simultaneously at 240"C over 2 hours. The Cd precursor consisted of 0.3 mmol Cd(oleate)2 and
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0.6 mmol oleylamine in a solvent mixture of octadecene (1.5 mL) and TOP (3 mL). The S
precursor consisted of 0.3 mmol hexamethyldisilathiane [(TMS) 2S] in 6 mL TOP. Addition of a
total of 5 monolayers of CdS yielded QDs with emission at 570 nm and a quantum yield close to
unity when diluted in octane.
Synthesis of CdSe(Cdo. 3Zno. 7S)-QD612. The synthesis follows previously reported procedures [3,
32]. The QY of the QD 612 was 50% in octane.
Synthesis of InAs/Cdo. 2 Zno.sS-QD 7so. The synthesis follows previously reported procedures [33].
The QY of the QD 750 was 35% in octane.
Synthesis of norbornene modified SBPIL (polymer 11). To conjugate organic dyes to QDs,
primary amine monomer (monomer 10) was incorporated to the polymer (Scheme 4, polymer
11). (1S,2S,4S)-bicyclo[2.2.1]hept-5-en-2-yl acetic acid (norbomene) was activated by N,N'-
Diisopropylcarbodiimide and hydroxybenzotriazole in anhydrous dimethylformamide(DMF) at
room temperature. The activated norbomene was reacted with polymer 11 in 1 xPBS. After the
reaction was completed, the reaction mixture was filtered with a 0.2 pm Tuffryn syringe filter
and dialyzed with DI water 4 times through a 5kDa molecular weight cut off (MWCO) spin
concentrator. After the purification, a drop of 1 M NaOH was added to deprotonate the imidazole
groups and water was evaporated in vacuo. Then, the polymer solution was redissolved in 2,2,2-
trifluoroethanol and filtered for further ligand exchange.
Ligand Exchange. 5 mg of the betaine PILs in 2,2,2-trifluoroethanol was added dropwise to
QDs in THE. After the polymer addition, we added 1mL of chloroform and 200pL of water and
stirred vigorously. Less than 1 minutes after stirring, we were able to see the QDs being
transferred to the water phase (supplementary fig). Then, we pipette the QD layer out pulled
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vacuum to remove leftover organic solvents and redisperse the QDs in IX PBS which was
followed by three times of dialysis to get rid of excess polymers.
5.7.3 Characterizations
Measurement of Quantum yield (QY). The QY of QD570 was measured relative to
Rhodamine 610 (QY 68% in ethanol) with excitation at 505 nm and QY of QD605 was
measured relative to Rhodamine 640 (QY 100% in ethanol with excitation at 535nm). Solutions
of QDs in octane (native CdSe/CdS QDs) or PBS (QDs after ligand exchanged with betaine PILs)
and dye in ethanol were optically matched at the excitation wavelength. Fluorescence spectra of
QD and dye were taken under identical spectrometer conditions in quadruplicate and averaged.
The optical density was kept below 0.1 at the )max, and the integrated intensities of the emission
spectra, corrected for differences in index of refraction and concentration, were used to calculate
the quantum yields using the expression QYQD = (Absorbance)dye/(Absorbance)QD x (Peak
Area)QD /(Peak Area)Dye X (nlQD solvent) 2 /(lDye solvent) 2 X QYDye.
Gel Filtration Chromatography (GFC). GFC was performed using an AKTAprime Plus
chromatography system from Amersham Biosciences equipped with a self-packed Superdex 200
10/100 column or Superose 6 10/300 column (to characterize QDs after ligand exchange) or
Superose 12 10/300 column (to characterize betaine PILs). PBS (pH 7.4) was used as the mobile
phase with a flow rate of 1.0 mL/min for Supersex 200 and Superose 12 or 0.5 mL/min for
Superose 6. Typical injection volume was 100 pL. Detection was achieved by measuring the
absorption at 280 nm.
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Agarose Gel Electrophoresis. Electrophoresis of QDs was performed using a OWL B1A
(Thermo) with 1% Omnipur agarose (EMD) in TAE (40 mM Tris-acetate, 1 mM EDTA, pH 8.3)
at 7.4 V/cm for 20 min. QDs were diluted to 150 nM in TAE and mixed with 6x loading buffer
(30% glycerol in H20) before loading onto the gel. Gels were visualized using handheld UV
lamp and homemade gel imaging system.
(-Potential Measurement. p-Potential was measured on Malvern Zetasizer Nano ZS90
instrument. zeta-potentials were measured in 0.1X PBS, in a Dip Cell, with conductivities
between 0.5-1 mS/cm. QD samples(5 pM) were measured in 0.1x PBS buffer. Values are
reported as the average of triplicate runs consisting of 100 scans each.
Dynamic Light Scattering (DLS). Light-scattering analysis was performed using Malvern
Zetasizer Nano ZS90 instrument. All QD samples were between 0.5 and 2 pM and filtered
through a 0.02 gm filter before analysis. Typical count rates were between 85 and 150 kHz. The
resulting ACF was fitted using the DTS (Nano) software employing a non-negative least-squares
fitting algorithm. Hydrodynamic radii were obtained from a mass-weighted size distribution
analysis and reported as the mean of triplicate measurements.
5.7.4 In vitro Experiments
Cell Culture. HeLa cells were grown in DMEM (Mediatech) with 10% Fetal Bovine Serum
(Invitrogen), 50 U/mL penicillin and 50 gg /mL streptomycin (Invitrogen). For the specific
labeling with the QD-SA conjugates, the cells were transfected using 1 PL Lipofectamine 2000
(Invitrogen), 0.2 pg of BirA-ER plasmid and 0.2 pg of AP-YFP-TM plasmid per well of an 8-
well chamber slide (LabTek). One mM biotin was added to the media during plasmid expression.
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Cells were imaged under 4 'C PBS the day after transfection. 1% Bovine Serum Albumin
(Sigma) was added to block nonspecific binding during specific binding studies of ligand-coated
quantum dots. Commercial BSA is known to contain biotin, and the stock BSA solution was
dialyzed with a 3 kDa cutoff dialysis tube three times for 8 h in PBS pH 7.4, in 4 'C.
5.7.5 In vivo Experiments
Nonspecific Binding of QDs to Serum. 5gM SBPIL QD570 CdSe(CdZnS) (20 pL) was mixed
with 100% FBS and 1 x PBS to final concentrations of FBS of 20%, 50%, and 95% (referred as
100% in the main text). The mixture was incubated for 4 h at 37 'C with gentle mixing. The
resultant QD size distribution was then measured using gel filtration chromatography. The
mixture was injected into a Superose 6 GL10/300 column (GE Healthcare, Piscataway, NJ) on an
Agilient 1100 series HPLC with an in-line degasser, autosampler, diode array detector, and
fluorescence detector (Roseville, CA). PBS (pH 7.4) was used as the mobile phase with a flow
rate of 0.5 mL/min and an injection volume of 50 gL. In order to selectively measure the signal
from the QD rather than FBS, the fluorescence at 570nm with excitation at 300nm was measured.
Intravital Microscopy. A mixture of nanoparticles coated with PEG (570 nm emission) and
betaine (612 nm emission) ligands was prepared. Concentrations were adjusted with in vitro
calibration to result in roughly equal photoluminescence intensity for all three nanoparticle
samples under 840nm multi-photon excitation. These QDs were administered intravenously
using a retro-orbital injection of 200gL with the adjusted concentrations, multi-photon imaging
was performed as described previously [34] on a custom-built multi-photon laser-scanning
microscope using confocal laser-scanning microscope body (Olympus 300; Optical Analysis
Corp.) and a broadband femtosecond laser source (High Performance MaiTai, Spectra- Physics).
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Image slices were taken at -60mW at sample surface every 2.76ptm up to 201gm deep and with
2.76x2.76pm pixels. Mosaic images were taken in raster pattern using a motorized stage (H 101,
Prior Scientific, Inc.) and customized automation software (LabView, National Instruments).
Imaging studies were performed with a 20X magnification, 0.95NA water immersion objective
(Olympus XLUMPlanFl, 1 -UB965, Optical Analysis).
Clearance Half-lives. In vivo clearance kinetics of SBPIL QDs was measured in non-tumor
bearing female SCID mice. Each mouse was anesthetized with a ketamine/xylazene solution
before intravenous infusion of nanoparticles by retro-orbital injection. For each time points, we
collected 13VL of blood via tail vein nick and mixed this sample with 3 gL 50 mM EDTA in a
plastic 96-well plate. To measure particle concentrations in the blood over time, we imaged in
these samples using multiphoton microscopy to measure average intensities.
Calculation of transvascular flux. Images were analyzed using custom analysis software
developed in MATLAB (The Mathworks). First, 3D vessel tracing [35] was performed to create
a vascular cast and a 3D map of voxel intensity versus distance to the nearest vessel over time.
Images were also corrected for sample movement over time with 3D image registration. The
normalized transvascular flux was calculated using the equation:
Jt p f,=R C(r)rr
= Pegg = lim--
S,(C, - C) t-o at (Cv - C)R
where Jt is the transvascular flux, S, is the vessel surface area, C, is the concentration of the
probe in the vessel, C is the concentration of the probe immediately extravascular, Peff is the
effective permeability [34], t is time after the initial image, r is the distance from the vessel
central axis, and R is the vessel radius at that point along the vessel. Fluorescence intensities
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were used as these concentrations. The calculation was made as an average over the entire
imaged volume for each tumor.
In vivo Biodistribution Study. In vivo biodistribution and tumor accumulation of the SBPIL
QDs were investigated by measuring the increase of cadmium concentration in various organs
after the SBPIL QD injection. The cadmium concentration was measured using inductively
coupled plasma mass spectroscopy (ICP-MS). For the ICP-MS experiments, heart, kidney, lunch,
liver, spleen, intestine, and tumor of mice were collected 24 hours after the retro-orbital injection
of the QDs and processed as follows. First, the organs were physically homogenized using a
hand homogenizer and dissolved in concentrated nitric acid (TraceSELECT* Ultra, for ultratrace
analysis, Fluka) in closed vessels at 120'C for 3 days. Digestion vessels, which were made of
Teflon, were cleaned before use by soaking them in 25% nitric acid for 3 days. After 3 days of
heating the nitric acid with the organds, the solutions became transparent (colorless or slightly
yellowish). Then, concentrated nitric acid was boiled off by opening the caps and heating the
vessels at 11 0"C for 4 hours. After all the nitric acids were removed, 0.2% nitric acid containing
1ppb In was added and the vessels were heated to 1 00C for 1 hours with the caps closed to
generate the final solutions that will be used for the ICP-MS measurements. Indium was added as
an internal standard since concentration of In is extremely low in live mice.
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